Electrosurgical cutting and sealing instruments with cam-actuated jaws

Information

  • Patent Grant
  • 9808308
  • Patent Number
    9,808,308
  • Date Filed
    Monday, August 4, 2014
    9 years ago
  • Date Issued
    Tuesday, November 7, 2017
    6 years ago
Abstract
Various embodiments are directed to a surgical instrument comprising, a shaft, and an end effector. The shaft may be coupled to the handle and may extend distally along a longitudinal axis. The end effector may be positioned at a distal end of the shaft and may comprise first and second jaw members and a reciprocating member. The first and second jaw members may define first and second longitudinal slots. One or both of the jaw members may be pivotable relative to the other about a pivot point. The reciprocating member may be translatable distally and proximally parallel to the longitudinal axis and through the first and second longitudinal slots. A distal portion of the reciprocating member may define a blade. The instrument may comprise an overtube translatable distally to exert a force on a portions of the first and second jaw members tending to close the first and second jaw members.
Description
BACKGROUND

Various embodiments are directed to electrosurgical cutting and sealing instruments with cam-actuated jaws that may be used, for example, in open and minimally invasive surgical environments.


Minimally invasive procedures are desirable because such procedures can reduce pain and provide relatively quick recovery times as compared to conventional open medical procedures. Many minimally invasive procedures are performed with an endoscope (including without limitation laparoscopes). Such procedures permit a physician to position, manipulate, and view medical instruments and accessories inside the patient through a small access opening in the patient's body. Laparoscopy is a term used to describe such an “endosurgical” approach using an endoscope (often a rigid laparoscope). In this type of procedure, accessory devices (such as end effectors for creating energy-induced tissue welds) are inserted into a patient through trocars placed through the body wall. Still less invasive treatments include those that are performed through insertion of an endoscope through a natural body orifice to a treatment region. Examples of this approach include, but are not limited to, cystoscopy, hysteroscopy, esophagogastroduodenoscopy, and colonoscopy.


Many of these procedures employ a flexible endoscope during the procedure. Flexible endoscopes often have a flexible, steerable articulating section near the distal end that can be controlled by the clinician by utilizing controls at the proximal end. Some flexible endoscopes are relatively small (1 mm to 3 mm in diameter), and may have no integral accessory channel (also called biopsy channels or working channels). Other flexible endoscopes, including gastroscopes and colonoscopes, have integral working channels having a diameter of about 2.0 to 3.7 mm for the purpose of introducing and removing medical devices and other accessory devices to perform diagnosis or therapy within the patient. For example, some end effectors are used to create an energy-induced weld or seal. Certain specialized endoscopes or steerable overtubes are available, such as large working channel endoscopes having a working channel of 5 mm, or larger, in diameter, which can be used to pass relatively large accessories, or to provide capability to suction large blood clots. Other specialized endoscopes include those having two or more working channels.


A common task both in minimally invasive and open surgical environments is to grasp, cut and fasten tissue while leaving the cut ends hemostatic (e.g., not bleeding). For example, it is often desirable to cut and seal bodily lumens, such as individual blood vessels or tissue including various vasculature. When sealing a fluid-carrying bodily lumen, it is often necessary for the seal to have sufficient strength to prevent leakage of the fluid, which may exert considerable fluid pressure.


Instruments exist for simultaneously making a longitudinal incision in tissue and fastening the tissue on opposing sides of the incision. Such instruments commonly include an end effector having a pair of cooperating jaw members that, if the instrument is intended for minimally invasive applications, are capable of passing through a cannula passageway or endoscopic working channel. In use, the clinician is able to close the jaw members to clamp the tissue to be cut. A reciprocating cutting instrument (or knife) is drawn distally along the jaw members to transect the clamped tissue. Simultaneously, a fastening mechanism fastens the cut ends of the tissue on opposing sides of the incision. Known fastening mechanisms include staples, sutures or various instruments utilizing energy sources. For example, various energy sources such as radio frequency (RF) sources, ultrasound sources and lasers have been developed to coagulate, seal or join together tissue volumes.


SUMMARY

Various embodiments are directed to a surgical instrument comprising an handle, a shaft, an end effector, and a reciprocating member. The shaft may be coupled to the handle and may extend distally along a longitudinal axis. The end effector may be positioned at a distal end of the shaft and may comprise first and second jaw members. The first and second jaw member may, respectively, define first and second longitudinal slots. Further, the second jaw member may be pivotable towards the first jaw member about a pivot point and comprising a cam pin positioned offset from the pivot point. The reciprocating member may be translatable distally and proximally parallel to the longitudinal axis through the first longitudinal slot and the second longitudinal slot. A distal portion of the reciprocating member may define a blade. The reciprocating member may define a cam slot for receiving the cam pin. Distal motion of the reciprocating member may exert a force on the cam pin such that the second jaw member pivots towards the first jaw member, and proximal motion of the reciprocating member exerts a force on the cam pin such that the second jaw member pivots away from the first jaw member.


Also, various embodiments are directed to a surgical instrument comprising a handle, a shaft, an end effector, a reciprocating member and an overtube. The shaft may be coupled to the handle and may extend distally along a longitudinal axis. The end effector may be positioned at a distal end of the shaft and may comprise first and second jaw members. The first and second jaw member may, respectively, define first and second longitudinal slots. Further, the first and second jaw members may be pivotable relative to one another about a pivot point and may comprise first and second cam portions positioned proximally from the respective pivot points. The reciprocating member may be translatable distally and proximally parallel to the longitudinal axis through the first longitudinal slot and the second longitudinal slot. A distal portion of the reciprocating member may define a blade. The overtube may be positioned over the shaft and may be translatable distally toward the pivot point. The overtube may also be configured to contact the first and second cam portions as it translates distally to apply a force on the first and second cam portions tending to close the first and second jaw members.


In addition, various embodiments are directed to a surgical instrument comprising a handle, a shaft, a reciprocating member, and an end effector. The shaft may be coupled to the handle and may extend distally along a longitudinal axis. The end effector may be positioned at a distal end of the shaft and may comprise first and second jaw members. The first and second jaw members may, respectively, define first and second longitudinal slots. The second jaw member may be pivotable relative to the first jaw member about the pivot point. The reciprocating member may comprise an I-beam member translatable distally and proximally relative to the longitudinal axis through the first longitudinal slot and the second longitudinal slot; and a blade member translatable distally and proximally separately from the I-beam member.





FIGURES

Various features of the embodiments described herein are set forth with particularity in the appended claims. The various embodiments, however, may be understood in accordance with the following description taken in conjunction with the accompanying drawings as follows.



FIG. 1 illustrates one embodiment of a transection and sealing instrument, which may be used, for example, with an endoscope.



FIG. 2 illustrates one embodiment of the transection and sealing instrument of FIG. 1 for use in electrosurgical applications.



FIGS. 3 and 4 illustrate one embodiment of an end effector of a surgical grasping instrument adapted for transecting captured tissue and contemporaneous sealing of the captured tissue with RF energy delivery.



FIGS. 5 and 6 illustrate one embodiment of the reciprocating member shown in FIGS. 3 and 4.



FIGS. 7 and 8 illustrate one embodiment of the actuation of a reciprocating member shown in FIG. 3 from a first retracted position to a second extended position to move the jaws of the end effector from an open position to a closed position.



FIG. 9 illustrates an end view of one embodiment of the reciprocating member of FIG. 3 with the jaws of the end effector in phantom view.



FIG. 10 illustrates a cross-sectional view of the embodiment shown in FIG. 9 along a cross-section taken at a position proximally located from the end view shown in FIG. 9.



FIG. 11 illustrates one embodiment of the jaw of the end effector of FIG. 3 de-mated from the end effector.



FIGS. 12-14 illustrate one embodiment of an end effector having a single rotating jaw member.



FIGS. 15-18 illustrate another embodiment of an end effector having a single rotating jaw member.



FIG. 19 illustrates one embodiment of the reciprocating member configured with separate elevated step or cam surfaces in the lower flange portions that are adapted to slidably engage the ends of the rectangular pins on either side of upper jaw.



FIG. 20 illustrates one embodiment of an end effector comprising cam-pin actuated jaw members.



FIG. 21 illustrates one embodiment of the reciprocating member of FIG. 20 showing the cam slot.



FIG. 22 illustrates one embodiment of the end effector of FIG. 20 in a closed position.



FIGS. 23-24 illustrate one embodiment of an end effector having a pair of movable, cam-pin actuated jaw members.



FIGS. 25 and 26 illustrate one embodiment of an end effector comprising cam-actuated jaw members in an open position.



FIGS. 27 and 28 illustrate one embodiment of the end effector of FIGS. 25 and 26 with the jaw members in a closed position.



FIG. 29 illustrates one embodiment of the reciprocating member of FIGS. 25-28.



FIG. 30 illustrates one embodiment of the reciprocating member of FIG. 29 with a shuttle and cam pin shown.



FIG. 31 illustrates one embodiment of the end effector of FIG. 25 with the clevis and the shaft shown in FIG. 25 not shown.



FIG. 32 illustrates one embodiment of the end effector as shown in FIG. 31 with the clevis also shown.



FIG. 33 illustrates one embodiment of the clevis of the end effector of FIG. 25.



FIGS. 34 and 35 illustrate one embodiment of the upper jaw member of the end effector of FIG. 25.



FIGS. 36 and 37 illustrate one embodiment of the lower jaw member of the end effector of FIG. 25.



FIGS. 38-40 illustrate one embodiment of an end effector comprising an overtube for providing closing force to jaw members.



FIGS. 41-43 illustrate one embodiment of a reciprocating member that may be used in any of the end effectors described above in order to allow closure of jaw members without the advancement of a blade.



FIG. 44 shows an example embodiment of a vessel having opposing wall portions.



FIG. 45 is a graphic illustration of one embodiment of the opposing vessel walls portions of FIG. 44 with the tissue divided into a grid with arbitrary micron dimensions.



FIG. 46 illustrates one embodiment of the blood vessel of FIG. 44 acted upon by a device implementing a power adjustment approach to energy delivery.



FIG. 47 illustrates one embodiment of the blood vessel of FIG. 44 acted upon by a device implementing a current-path directing approach to energy delivery.



FIG. 48 illustrates one embodiment of an endoscope (illustrated here as a gastroscope) inserted into the upper gastrointestinal tract of a patient.



FIG. 49 illustrates one embodiment of a distal portion of the endoscope of FIG. 48, which may be used with the transection and sealing instrument described herein.





DESCRIPTION

Various embodiments are directed to electrosurgical devices for cutting and sealing, for example, cutting and sealing a bodily lumen. According to various embodiments, the electrosurgical devices may comprise a cam-actuated end effector. The cam-actuated end effector may comprise a pair of jaw members and a reciprocating member that may be translatable distally through the jaw members to provide a clamping force tending to force the jaw members together and to transect tissue between the jaw members with a sharpened leading edge. The jaw members may comprise electrodes and/or another electrically active surface for sealing tissue (e.g., tissue that has been severed). Some embodiments of the end effectors may be bilateral (both jaw members are pivotable) or unilateral (only one jaw member is pivotable).


According to various embodiments, the reciprocating member may define a cam slot configured to receive a cam pin coupled to a movable jaw member. Distal and proximal movement of the reciprocating member may cause the cam pin to translate within the cam slot, which may, in turn, cause the movable jaw member to pivot from an open position (e.g., proximal position of the reciprocating member) to a closed (e.g., distal position of the reciprocating member). In embodiments where two jaw members are movable, both jaw members may comprise a cam pin and the reciprocating member may define a pair of cam slots or grooves. The cam-actuated nature of the jaw member or members may increase the acuity of the instrument and allow the clinician to increase the force with which the jaw members are opened. This may make the surgical instrument useful for dissecting as well as for cutting and sealing.


According to various embodiments an end effector may comprise a pair of movable jaw members pivotable about a pivot pin or other pivot point. The jaw members may comprise a cam portion proximal of the pivot point. Each cam portion may define a cam slot. A shuttle may comprise one or more cam pins received within the cam slots. Distal and proximal movement of the shuttle may cause the cam pin or pins to slide within the respective cam slots of the jaw members. This may, in turn, cause the jaw members to open and close. In some embodiments, an overtube may be provided. The overtube may extend distally and contact the cam portions of the jaw members, forcing them towards a longitudinal axis of the end effector.


According to various embodiments, the reciprocating member of any of the end effectors described above may comprise an I-beam member and a blade member. The I-beam member may define a slot for receiving the blade member such that the blade member may translate distally and proximally relative to the I-beam member. In use, the I-beam member may be translated distally separately from the blade member. In this way, the I-beam member may act to close the jaw members, and/or to provide a clamping force tending to force the jaw members together without the blade member extending to transect tissue or material present between the jaw members. The blade member may then be separately extended to transect the tissue or material. In this way, the end effector may be used for grasping as well as for cutting and sealing.



FIG. 1 illustrates one embodiment of a transection and sealing instrument 100. The instrument 100 may be used with an endoscope, laparoscope, or any other suitable introduction device. According to various embodiments, the transection and sealing instrument 100 may comprise a handle assembly 102, a shaft 104 and an end effector 106. The shaft 104 may be rigid (e.g., for laparoscopic application and/or open surgical application) or flexible, as shown, (e.g., for endoscopic application). In various embodiments, the shaft 104 may comprise one or more articulation points (e.g., in embodiments where the shaft 104 is rigid). The end effector 106 may comprise a first jaw member 108 and a second jaw member 110. The first jaw member 108 and second jaw member 110 may be connected to a clevis 112, which, in turn, may be coupled to the shaft 104. In various embodiments, as illustrated below, the jaw members 108, 110 may be directly coupled to the shaft 104 and the clevis 112 may be omitted. As illustrated in FIG. 1, the end effector 106 is shown with the jaw members 108, 110 in an open position. A reciprocating blade/I-beam member 340 is illustrated between the jaw members 108, 110.


According to various embodiments, one or both of the jaw members 108, 110 may include, or serve as electrodes in monopolar or bi-polar electrosurgical applications including, for example, cutting, coagulation and welding. FIG. 2 illustrates one embodiment of the transection and sealing instrument 100 for use in electrosurgical applications. The jaw members 108, 110 of the end effector 106 may comprise respective electrodes 120, 122. The electrodes 120, 122 may be connected to an electrosurgical generator 124 via wires (not shown) extending from the end effector 106 through the shaft 104 and handle 102. The generator 124 may generate any suitable type of signal for electrosurgical applications. For example, the generator 124 may make various alternating current (A/C) and/or direct current (D/C) signals at suitable voltages, currents, frequencies and wave patterns. According to various embodiments, the transection and sealing instrument 100 may be configured for monopolar operation. In this case, the end effector 106 may comprise a single electrode, rather than two. According to various embodiments, all or a portion of the end effector 106 may serve as the single electrode.


A translating member 116 may extend within the shaft 104 from the end effector 106 to the handle 102. The translating member 116 may be made from any suitable material. For example, the translating member 116 may be, a metal wire (e.g., a tri-layered steel cable), a plastic or metal shaft, etc. In some embodiments, one or more additional translating members (not shown in FIG. 2) may be included to control the motion of the end effector 106 and/or the shaft 104. In various embodiments, the instrument 100 may comprise multiple translating members 116, for example, as described below. At the handle 102, the shaft 104 may be directly or indirectly coupled to an actuator 113 (FIG. 1). In use, a clinician may cause the actuator 113 to pivot along arrow 118 from a first position to a second position. When the actuator moves from the first position to the second position, it may translate the translating member 116 distally or proximally. Distal or proximal motion of the translating member 116 may, in turn, cause the end effector 106 to transition from an open position to a closed position (or vice versa) and/or to perform various other surgical activities such as, for example, severing and/or joining or welding. According to various embodiments, the handle 102 may comprise multiple actuators 113. When multiple actuators 113 are present, each actuator 113 may be used by a clinician to cause the end effector 106 to perform different surgical activities. In various embodiments a single actuator 113 may cause the end effector 106 to perform more than one activity. For example, a clinician may activate a single actuator 113 to force a reciprocating member 340 distally. This may, as described, both close the jaw members 108, 110 and transect any tissue between the jaw members 108, 110.



FIGS. 3 and 4 illustrate one embodiment of an end effector 106 of the instrument 100 adapted for transecting captured tissue and contemporaneous sealing of the captured tissue with RF energy delivery. The end effector 106 is carried at the distal end 304 of the shaft 104 that can be rigid, articulatable or deflectable in any suitable diameter. For example, the shaft 104 can have a diameter ranging from about 2 mm to 20 mm to cooperate with cannulae in endoscopic/laparoscopic surgeries or for use in open surgical procedures. The shaft 104 extends from a proximal handle, such as the handle 102. The handle 102 can be any type of pistol-grip or other type of handle known in the art that carries actuator levers, triggers or sliders for moving the translating member 116 or members distally and proximally to actuate the jaws as will be disclosed below. The shaft 104 has a bore 308 extending therethrough for carrying actuator mechanisms (e.g., translating member 116) for actuating the jaws and for carrying electrical leads 309a-309b for the electrosurgical components of the end effector 106.



FIGS. 3 and 4 show details of the end effector 106, including the (upper) jaw element 108 and (lower) jaw element 110 that are adapted to close or approximate along an axis 315. The jaw elements 108, 110 may both be moveable or a single jaw may rotate to provide the open and closed positions. In the example embodiment of FIGS. 1 and 2, both the lower and upper jaws 110, 108 are moveable relative to a rolling pivot location 316 defined further below.


An opening-closing mechanism of the end effector 106 operates on the basis of cam mechanisms that provide a positive engagement of camming surfaces both distal and proximal to a pivoting location (i) for moving the jaw assembly to the (second) closed position to engage tissue under very high compressive forces, and (ii) for moving the jaws toward the (first) open position to apply substantially high opening forces for “dissecting” tissue. This feature allows the surgeon to insert the tip of the closed jaws into a dissectable tissue plane—and thereafter open the jaws to apply such dissecting forces against the tissues.


According to various embodiments, the lower and upper jaws 110, 108 may have a first end 318, in the open position, that defines first (proximally-facing) arcuate outer surface portions indicated at 320a and 320b that are engaged by a first surface portions 322a and 322b of a reciprocating I-beam member 340 (FIG. 4) that is adapted to slide over the jaw elements 108, 110 to thereby move the jaws toward closed position. FIGS. 5 and 6 show views that illustrate the cam surfaces of reciprocating member 340 de-mated from jaws 110 and 108. The first end portion 318 of the lower and upper jaws, in the open position, further defines second (distally-facing) arcuate surface portions indicated at 330a and 330b that are engaged by second surface portions 332a and 332b (FIG. 5) of the reciprocating member 340 for moving the jaw elements to the open position. The effective point of jaw rotation may lie between the first and second arcuate cam surfaces of the jaws. The distal (second) end region 333 of the paired jaws is rounded with a lip 334 that can serve as an electrode for surface coagulation as will be described below.


In this embodiment of FIGS. 3, 4 and 5, the reciprocating member 340 may be actuatable from the handle of the instrument by any suitable mechanism, such as actuator 113. For example, the actuator 113 may be coupled to a proximal end 341 of the member 340 and/or may be coupled to a translating member or members 116 that are, in turn, coupled to the reciprocating member. The proximal end 341 and medial portion 341′ of member 340 are dimensioned to reciprocate within bore 308 of the shaft 104. The distal portion 342 of reciprocating member 340 carries first (lower) and second (upper) laterally-extending flanges or shoulder elements 344A and 344B that are coupled by an intermediate transverse element 345. The transverse element 345 further is adapted to transect tissue captured between the jaws with a leading edge 346 (FIG. 5) that can be a blade or a cutting electrode. The transverse element 345 is adapted to slide within channels 348a and 348b in the paired first and second jaws 110, 108. As can be seen best in FIGS. 5 and 6, the laterally-extending shoulder elements 344A and 344B define the surfaces 322a, 322b, 332a, 332b that slidably engage the arcuate cam surfaces of the jaws and that apply high compressive forces to the jaws in the closed position.


According to various embodiments, the first and second jaws 108 and 110 may define tissue-engaging surfaces or planes 350a and 350b that contact and deliver energy to engaged tissues, in part, from RF electrodes 120, 122. The engagement plane 350a of the lower jaw 110 may be adapted to deliver energy to tissue, and the tissue-contacting surface 350b of upper jaw 108 may be electro surgically active or passive as will be described below. Alternatively, the engagement surfaces 350a, 350b of the jaws can carry any suitable electrode arrangement known in the art.


The jaws 108, 110 may have teeth or serrations 356 in any location for gripping tissue. The embodiment of FIGS. 3 and 4 depicts such serrations 356 at an inner portion of the jaws along channels 348a and 348b thus leaving engagement planes 350a and 350b laterally outward of the tissue-gripping elements. The serrations 356 may be of any suitable symmetric or asymmetric shape or combination of shapes including, for example, triangular, rounded, sinusoidal, etc. In the embodiments described below, the engagement planes 350a and 350b and electrode(s) 120, 122 generally are shown with a non-serrated surface for clarity of explanation, but such engagement planes and electrodes themselves can be any non-smooth gripping surface. The axial length of jaws 108, 110 indicated at L can be any suitable length depending on the anatomic structure targeted for transection and sealing. In various embodiments, the length L may be between 10 mm and 50 mm. In some embodiments, the length L may be longer. For example, one embodiment of an end effector 106 for resecting and sealing organs such as a lung or liver may have a length L of about 200 mm. Also, for example, for some surgical tasks, the jaws having a shorter length L may be used, including, for example, jaws having a length L of about 5.0 mm.



FIG. 9 illustrates an end view of one embodiment of the reciprocating member 340 with the jaws 110 and 108 in phantom view. The view shown in FIG. 9 is a head-on view with the distally positioned blade surface 346 pointed out of the page. FIG. 10 illustrates a cross-sectional view of the embodiment shown in FIG. 9 along a cross-section taken at a position proximally located from the end view shown in FIG. 9. The transverse element 345 of the reciprocating member 340 may define a transverse dimension d between innermost surfaces 358a and 358b of the flanges 344A, 344B of the reciprocating member 340 and cooperating medial and distal outer surfaces 360A and 360B of the jaws. The selected transverse dimension d between the flanges or shoulders 344A and 344B thus further defines the engagement gap g between the engagement planes 350a and 350b of the jaws in the closed position. It has been found that very high compression of tissue combined with controlled RF energy delivery is optimal for welding the engaged tissue volume contemporaneous with transection of the tissue. According to various embodiments, the engagement gap g between the engagement planes 350a, 350b may range from about 0.001″ to about 0.050″. For example, the gap g between the engagement planes ranges from about 0.001″ to about 0.010″. As can be seen in FIGS. 5 and 10, the medial portion 341′ of the reciprocating member 340 may have an “I”-beam shape with inner surface portions 363a and 363b that engage the cooperating medial outer surfaces of the jaws. Thus, in various embodiments, the entire length L of the jaws can be maintained in a fixed spaced-apart relationship to define a consistent engagement gap g. According to various embodiments, the engagement gap g may be selected to be large enough to prevent tissue engaged between the jaws 108, 110 from being sheared and to prevent electrical shorts between the electrodes 120, 122.



FIGS. 7 and 8 illustrate one embodiment of the actuation of the reciprocating member 340 from a first retracted position to a second extended position to move the jaws 110 and 108 from an open position to a closed position. Referring to FIG. 7, it can be seen that the translatable member 340 is being moved in the proximal direction so that the proximal-facing surfaces 332a and 332b (FIG. 5) of reciprocating member 340 about the outer surfaces 330a and 330b of the jaws thus forcing the jaws apart, for example to apply dissecting forces to tissues or to open jaws 108 and 110 to engage targeted tissues for hemostasis and transection. FIG. 8 shows the reciprocating member 340 after having been fully extended in the distal direction so that the distal-facing surfaces 322a and 322b of reciprocating member 340 have ridden up and over the proximal arcuate surfaces 320a and 320b of the jaws (and medial outer surfaces 360A and 360B) thus forcing the jaws together thereby producing a compressive force between jaws 108 and 110. According to various embodiments, the orientation of surfaces 322a, 322b of the reciprocating member 340 and/or the arcuate surfaces 320a, 320b may be modified to modify the compression rate provided by the reciprocating member 340. For example, the orientation of the 322a, 322b of the reciprocating member 340 and/or the arcuate surfaces 320a, 320b may vary from one embodiment to another, or may vary within a single embodiment in order to cause variable compression rates within a single stroke of the reciprocating member 340.


According to various embodiments, the jaws 108, 110 may rollably contact one another along the interface 370 between inner surfaces 372 of the first end 318 of the jaws. As jaws 108 and 110 articulate, the pivot point is moving as the point of contact changes at the interface between surfaces 370 and 372. Thus, the jaw assembly may not need to define a true single pivot point as is typical of hinge-type jaws known in the art. The pivotable action of the jaws along interface 370 may be described as a rolling pivot that optionally can allow for a degree of dynamic adjustment of the engagement gap g at the proximal end of the jaws. FIG. 11 illustrates one embodiment of the jaw 108 de-mated from the end effector 106. Referencing FIG. 11, the jaws elements 110, 108 can be retained relative to one another and the shaft 104 by means of protruding elements 375 that couples with arcuate slots 376 in an internal member 377 that is fixedly carried in bore 308 of shaft 104. Alternatively, outwardly protruding elements can cooperate with slots in the wall of shaft 104. Also, for example, the jaw assembly may (optionally) comprise springs for urging the jaws toward the open position, or closed position depending on the desired at-rest state of the device.



FIGS. 12-13 illustrate one embodiment of an end effector 1200 having a single rotating jaw member. Like the end effector 106 described above, the end effector 1200 is carried at the distal end 304 of the shaft 104 that has a bore 308 extending therethrough. According to various embodiments, the first (lower) jaw 1210 may be a fixed extension portion of the shaft 104. As can be seen in FIGS. 12 and 13, the second (upper) jaw 1208 is adapted to close or approximate along longitudinal axis 1215.


The opening-closing mechanism of end effector 1200 may provide cam surfaces for positive engagement between reciprocating member 340 and the jaws (i) for moving the jaws to a closed position to engage tissue under high compressive forces, and (ii) for moving the jaws toward the (first) open position thereby providing high opening forces to dissect tissue with outer surfaces of the jaw tips. The reciprocating member 340 operates as described previously to reciprocate within bore 308 of the shaft 104. As can be seen in FIG. 13, the distal end portion 342 of reciprocating member 340 carries distal first and second laterally-extending flange portions 344A and 344B with the blade-carrying transverse element 345 extending therebetween. The blade-carrying member slides within channels 348a and 348b in the jaws.


In the example embodiment of FIGS. 12 and 13, the first and second jaw members 1210 and 1208 again define engagement surfaces or planes 1250a and 1250b that deliver energy to engaged tissue. The engagement planes may carry one or more conductor/electrodes 1255 and, in various embodiments, may comprise a PTC matrix 1285 in at least one of the jaws' engagement surfaces 1250a and 1250b. In the embodiment of FIGS. 12 and 13, the upper jaw 1208 has a proximate end region 1258 that, in the open position, defines a first (proximally-facing) arcuate cam surface indicated at 1260 that is engaged by a first surface portion 1562 of the reciprocating member 340. The first (proximal) end region 1258 of the upper jaw, in the open position, further defines second (distally-facing) surface portions indicated at 1270a and 1270a′ that are engaged by second surface 1272 of reciprocating member 340 for moving the jaw assembly to an open position.


As can be seen best in FIG. 13, the cam surfaces 1270a and 1270a′ may be formed into pins or projecting elements 1274 and 1274′ that may serve multiple purposes. Referring to FIG. 14, the pins 1274 and 1274′ extend through the upper jaw body 1276b and are received within arcuate bores 1277 in body 1276a of lower jaw 1210. The lower portions 1278 (collectively) of the pins 1274 and 1274′ thus can retain upper jaw 1208 and prevent it from moving axially or laterally relative to the jaw axis 1215 while still allowing the jaw's rotation for opening and closing. The pin mechanism further allows for greatly simplified assembly of the instrument.


The pins 1274 and 1274′ may provide additional functionality by providing a degree of “vertical” freedom of movement within the first (proximal) end portion 1258 of the jaw. As can be seen in FIGS. 12 and 19, the distal laterally-extending flange portions 344A and 344B define a transverse dimension d (cf. FIG. 19) that in turn determines the dimension of the engagement gap g of the distal end of the jaws in the jaw-closed position (FIG. 14). The transverse dimension d equals the dimension between inner surfaces of flange portions 344A and 344B that slidably contact the outer surfaces of both jaws.



FIGS. 15-18 illustrate another embodiment of an end effector 1500 that provides both electrosurgical functionality and improved grasping and dissecting functionality for endoscopic surgeries. In FIGS. 15-18, both the upper and lower jaws are shown in cut-away views to show internal cam surfaces of the upper jaw 1510 and the reciprocating member 340. The jaw assembly 1500 may carry engagement surfaces for applying electrosurgical energy to tissue as in the previously described embodiments, as well as cutting means for transecting the engaged tissue volume. The jaw assembly 1500 relates to the ability of the jaw structure, in one mode of operation, to be used for general grasping and dissecting purposes wherein the distalmost tips 1513 of the jaws can close tightly on tissue with little movement of the actuator lever 113 in the handle of the instrument. At the same time, in another mode of operation, the jaw assembly 1500 can close to apply very high compressive forces on the tissue to enable welding. Thus, the jaw structure may provide (i) a first non-parallel jaw-closed position for grasping tissue with the distal jaws tips (FIG. 17), and (ii) a second parallel jaw-closed position for high compression of tissue for the application of electrosurgical energy (FIG. 18).


Referring to FIG. 15, the end effector 1500 again has a shaft 104 that is similar to the shaft 104 as used by the end effector 1200 with first (lower) jaw 1510 comprising a fixed extending portion 1514 of the shaft 104. As can be seen in FIG. 15, the second (upper) jaw 1508 is adapted to close or approximate about longitudinal axis 1515. The opening-closing mechanism of jaw assembly 1500 provides cam elements and cooperating jaw surfaces for positive engagement between the reciprocating member 340 as described previously (i) for moving the jaws to a closed position to engage tissue, and (ii) for moving the jaws toward the open position thereby providing high opening forces to dissect tissue with outer surfaces of the jaw tips 313.


The reciprocating member 340 (FIG. 19) operates as described previously to reciprocate within bore 308 of the shaft 104 (FIG. 15). As can be seen in FIG. 15, the distal end 342 of the reciprocating member 340 again carries distal flange portions 344A and 344B with a blade-carrying transverse portion 345 therebetween. The transverse portion 345 slides within channels 348a and 348b in the paired jaws. In the example embodiment of FIG. 15, the first and second jaws 1510 and 1508 again define engagement surfaces 1550a and 1550b that can deliver electrosurgical energy to engaged tissue.


In the embodiment of FIG. 15, the upper jaw 1508 has a proximal end 1558 that defines a first (proximally-facing) arcuate jaw surface 1560 that is engaged by a first cam surface element 1562 of reciprocating member 340 for opening the jaw. The proximal end 1558 of the upper jaw further defines second (distally-facing) jaw surface portions indicated at 1570a and 1570a′ that are engaged by second cam element 1572 of reciprocating member 340 for moving the jaw assembly to an open position.


The embodiment of FIG. 15 shows that the upper jaw 1508 has a floating primary pivot location indicated at P1 that is provided by the projecting elements or rectangular pins 1574 (collectively) on either side of the channel portions 348 a that slidably extend into bores 1577 (collectively) in the lower jaw body (cf. FIG. 14). The lower portions of the pins 1574 thus allow upper jaw 1508 to rotate while at the same time the pin-and-bore mechanism allows the upper jaw to move upwardly away from the lower jaw.


For example, the degree of “vertical” freedom of movement of the upper jaw allows for the system to “tilt” the distal tip 1513 of upper jaw 1508 toward the axis 1515 to thereby allow the distal jaw tips 1513 to grasp tissue. This is termed a non-parallel closed position herein. The tilting of the jaw is accomplished by providing a plurality of cam surfaces in the upper jaw 1508 and the reciprocating member 340.


As can be seen in FIGS. 15 and 19, the lower and upper laterally-extending flange portions 344A and 344B of the reciprocating member 340 define a transverse dimension d that determines the dimension of gap g between the engagement surface of the jaws in the fully jaw-closed position (FIG. 18). The transverse dimension d equals the dimension between inner surfaces of flange portions 344A and 344B that slidably contact the outer surfaces of both jaws.



FIG. 19 illustrates one embodiment of the reciprocating member 340 configured with separate elevated step or cam surfaces 1590 in the lower flange portions 344A that are adapted to slidably engage the ends 1595 of the rectangular pins 1574 on either side of upper jaw 1508. The elevated cam surfaces 1590 of reciprocating member 340 thus create another transverse dimension d′ between inner surfaces of the flange portions 344A and 344B that move the jaws toward either the first jaw-closed position or the second jaw-closed position.


Now turning to FIGS. 15-18, the sequence of cut-away views illustrate how the multiple cam surfaces cause the jaws to move between a first “tilted” jaw-closed position to a second “high-compression” jaw-closed position. In FIG. 15, the jaws are in an open position. In FIG. 16, the reciprocating member 340 is moved distally and its cam surface element 1562 pushes on jaw surfaces 1560 to move the jaws toward a closed position wherein the jaws rotate about primary pivot location P1. In FIG. 16, it can be seen that the elevated cam surfaces 1590 in the lower flange 344A have not yet engaged the ends 1595 of the rectangular pins 1574.


Now turning to FIG. 17, the reciprocating member 340 is moved further distally wherein the elevated cam surfaces 1590 of lower flange 344A have now engaged and elevated the ends 1595 of rectangular pins 1574 thereby tilting the upper jaw. The upper jaw 1508 is tilted slightly by forces in the direction of the arrows in FIG. 17 as the upper flange 1544B holds the upper jaw 1508 at a secondary pivoting location indicated at P2—at the same time that the step of the cam surface element 1590 lifts the pins 1574 and the proximal portion 1558 of the upper jaw 1508 upward.


Thus, the system functions by providing a slidable cam mechanism for lifting the proximal end of the jaw while maintaining the medial jaw portion in a fixed position to thereby tilt the distal jaw to the second jaw-closed position, with the pivot occurring generally about secondary pivot P2 which is distal from the primary pivot location P1.



FIG. 18 next shows the reciprocating member 340 moved further distally wherein the elevated cam surfaces 1590 of lower flange 344A slides distally beyond the ends 1595 of rectangular pins 1574 thus causing the flanges 344A and 344B together with the trailing edge portions 1575 of the “I”-beam portion (FIG. 19) of the member 340 to apply very high compression forces over the entire length of the jaws as indicated by the arrows in FIG. 18. This position is termed a parallel jaw-closed position herein. Another advantage is that the jaw structure is in a “locked” position when the reciprocating member 340 is fully advanced.



FIG. 20 illustrates one embodiment of an end effector 2000 comprising cam-pin actuated jaw members 2008, 2010. Tissue 2020 is shown between the members 2008, 2010. The end effector 2000 may provide increased opening force allowing it to be used in more dissecting applications. By increasing the functions that may be performed by the end effector 2000, the number of instrument changes during a procedure may be minimized. The upper rotating jaw member 2008 may pivot relative to the lower jaw member 2010 about a rolling pivot P2. As illustrated, the jaw member 2008 may comprise a cam pin 2002 which extends through a cam slot 2004 defined by the reciprocating member 340′. The cam pin 2002 may be offset from the pivot point such that motion of the cam pin 2002 may tend to cause motion of the jaw member 2008. FIG. 21 illustrates one embodiment of the reciprocating member 340′ showing the cam slot 2004. FIG. 22 illustrates one embodiment of the end effector 2000 in a closed position.


The cam slot 2004 may have a distal portion 2016, a transition portion 2014 and a proximal portion 2012 (Figure A2). The distal portion 2016 may be positioned low in the member 340′ such that when the cam pin 2002 rides within the distal portion 2016 of the cam slot 2004, the jaw member 2008 may pivot about the pivot P2 to the open position shown in FIG. 20. To close the jaw members 2008, 2010, the reciprocating member 340′ may be pushed distally. As described above, transverse member 345 of the reciprocating member 340′ may slide within respective slots 2038a, 2038b in the jaw members 2008, 2010. Flange portions 344B of the reciprocating member 340′ may contact the jaw member 2008, forcing it to the closed position as described herein. Additionally, as the member 340′ moves distally, the cam pin 2002 of the jaw 2008 may be pushed through the distal portion 2016 of the cam slot 2004, through the transition portion 2014 and into the proximal portion 2012. This may raise the portion of the jaw member 2008 including the cam pin 2002 relative to the pivot P2, causing the jaw member 2008 to transition to the closed position shown in FIG. 22. Once the jaw member is in the closed position shown in FIG. 22, the member 340′ may be pushed further in the distal direction to hold the jaw members 2008, 2010 together and/or to cause the distal edge 346 of the member 340′ to transect tissue 2020.


Retracting the member 340′ in the proximal position may cause the cam pin 2002 to translate from the proximal portion 2012, through the transition portion 2014 to the distal portion 2016. The process may serve to force the jaw member 2008 to the open position shown in FIG. 20. This opening process may be utilized by clinicians to transect tissue, dissect tissue and/or insert targeted tissues into the jaws during surgery during surgery. According to various embodiments, the cam pin embodiments described herein may provide superior opening force, allowing the clinician to use the end effector 2000 for dissection tasks that previously required a separate instrument.


The cam pin concept shown in FIGS. 20-22 may also be used in embodiments having two movable jaw members. For example, FIGS. 23-24 illustrate one embodiment of an end effector 2300 having a pair of movable, cam-pin actuated jaw members 2308, 2310. The jaw members 2308, 2310 may be pivotable about a pivot pin 2302. The pin 2302 may be coupled to the shaft 104, as shown, or may be coupled to a clevis (not shown in FIG. 23), for example, as illustrated by clevis 112 shown in FIG. 1 above. The jaw members 2308, 2310 may comprise respective cam portions 2307, 2305. The cam portions 2307, 2305 may, in turn, comprise respective cam pins 2304, 2306. The cam pins 2304, 2306 may ride within a pair of cam slots 2312, 2314 of a reciprocating member 340″. According to various embodiments, the cam slots 2312, 2314 may not extend all the way through the member 340″ (e.g., the cam slots 2312 may thought of as cam grooves). This may prevent the respective pins 2304, 2306 from interfering with one another.


Each of the cam slots 2314, 2312 may comprise distal portions 2320, 2346, transition portions 2318, 2344, and proximal portions 2316, 2322. When the member 340″ is pulled proximally, as shown in FIG. 23, the jaw members 2308, 2310 may be in the illustrated open position and the cam pins 2304, 2306 may rest in the distal portions 2320, 2346 of the respective cam slots 2312, 2314. To close the jaws, the reciprocating member 340″ may be pushed distally, as shown in FIG. 24. This may cause the cam pins 2304, 2306 to slide from the distal portions 2320, 2346 through the transition portions 2318, 2344 to the proximal portions 2316, 2322 of the cam slots 2312, 2314. This may, as shown, cause the jaw members 2308, 2310 to pivot about the pivot pin 2302 to the closed position shown in FIG. 24. To open the jaw members 2308, 2310, the reciprocating member 340″ may be pulled distally to the position shown in FIG. 23. This may cause the cam pins 2304, 2306 to transition back to the distal portions 2320, 2346 of the cam slots 2312, 2316 which, in turn, may force the jaw members 2308, 2310 to the open position.



FIGS. 25 and 26 illustrate one embodiment of an end effector 2500 comprising cam-actuated jaw members 2502, 2504 in an open position. The jaw members 2502, 2504 may be pivotably coupled to a clevis 2514 at a pivot point 2516 such that the jaw members 2502, 2504 may transition from the open position shown in FIGS. 25 and 26 to the closed position shown in FIGS. 27 and 28 and described below. As shown in FIGS. 25-28, both jaw members 2502, 2504 may be pivotable about the pivot point 2516. In some embodiments, however, one of the jaw members may be stationary. The pivot point 2516 may be any suitable kind of joint and, in various embodiments, may comprise a pin. The jaw members 2502, 2504 may comprise tissue-engaging surfaces or planes 2536a, 2536b that may be similar to the tissue engaging planes 350a, 350b described above and may be, or comprise, one or more electrodes for delivering energy to tissue held between the jaw members 2502, 2504, as described herein. Wire conduits 2542, 2544, 2546 may be present, as shown, to carry wires from the electrodes to the generator 324, e.g., via the shaft 104.


Each of the jaw members 2502, 2504 may comprise respective cam portions 2506, 2508 positioned substantially or entirely proximally from the pivot point 2516. The cam portions 2506, 2508 may define cam slots 2510, 2512. A shuttle 2520 may be coupled to the cam portions 2506, 2508 via a cam pin 2518 received through both of the cam slots 2510, 2512. According to various embodiments, the cam pin 2518 may comprise two cam pins on opposite sides of the shuttle 2520. Also, according to various embodiments, the drive pin 2518 or pins may not extend all the way through the cam slots 2510, 2512.


The cam slots 2510, 2512 may be curved such that distal motion of the shuttle 2520 may cause the jaw members 2502, 2504 to pivot about the pivot point 2516 to the open position shown in FIG. 25. Similarly, proximal motion of the shuttle 2520 may cause the jaw members 2502, 2504 to pivot about the pivot point 2516 to a closed position, for example, as shown in FIGS. 27 and 28. Distal and proximal motion of the shuttle 2520 may be effected by a translating member 2530 (FIG. 30), which may extend proximally to the handle 102. At the handle 102, an actuator, such as actuator 113 may be coupled to the translating member 2530 such that a clinician may move the actuator 113 in order to cause distal and proximal motion of the translating member 2530. Distal and proximal motion of the translating member 2530 may cause similar distal and proximal motion of the shuttle 2520, which may, in turn cause the jaws 2502, 2504 to open and close.


The end effector 2500 may also comprise a reciprocating I-beam member 2524 similar to the member 340 described above. FIG. 29 illustrates one embodiment of the reciprocating member 2524. The member 2524 may comprise a transverse element 2532 and a pair of flanges 2528a, 2528b. The transverse element 2532 may comprise a distally directed leading edge or blade 2526, which may be sharpened or be electrically active to cut tissue. When the jaw members 2502, 2504 are in the closed position shown in FIGS. 27 and 28, the transverse element may be translated distally to cut tissue held between the jaw members 2502, 2504 and, in various embodiments, to provide a compressive force tending to hold the jaw members 2502, 2504 together. For example, the transverse element 2532 of the reciprocating member 2524 may be adapted to slide within slots 2534a, 2534b in the jaw members 2502, 2504. Flanges 2528a, 2528b may ride above the slots 2534a, 2534b. As the reciprocating member 2524 is translated distally through the slots 2534a, 2534b, the flanges 2528a, 2528b may exert a compressive force on the jaw members 2502, 2504, tending to force the jaw members 2502, 2504 together. The reciprocating member 2524 may be actuatable from the handle 102 of the instrument by any suitable mechanism, such as actuator 113, which may be coupled to a proximal end of member 2524. The proximal end and medial portion of member 340 may be dimensioned to reciprocate within bore 308 of the shaft 104.


According to various embodiments, the reciprocating member 2524 and the shuttle 2520 may be configured to translate distally and proximally substantially independent of one another. For example, the reciprocating member 2524 may define a slot 2536 in the transverse member 2532 for receiving the shuttle 2520 and the cam pin 2518. FIG. 30 illustrates one embodiment of the reciprocating member 2524 with the shuttle 2520 and cam pin 2518 shown. The shuttle 2520 and cam pin 2518 may be movable transversely and distally relative to the reciprocating member 2524 (e.g., as shown by arrow 2538). In this way, the reciprocating member 2524 may have a range of motion along the arrow 2538 while the shuttle 2520 is stationary. Likewise, the shuttle 2520 may have a range of motion along the arrow 2538 while the reciprocating member 2524 remains stationary.



FIG. 31 illustrates one embodiment of the end effector 2500 with the clevis 2514 and the shaft 104 shown in FIG. 25 omitted. The cam pin 2518 is shown riding within the slot 2536 in the reciprocating member 2524 as well as within the slot 2510 of the cam portion 2506 of the jaw member 2502. A coupling 2540 for fastening the clevis 2514 to the shaft 104 is also illustrated. FIG. 32 illustrates one embodiment of the end effector 2500 as shown in FIG. 31 with the clevis 2514 also shown. FIG. 33 illustrates one embodiment of the clevis 2514. The clevis 2514 may comprise a pair of arms 2554, 2556. Each arm 2554, 2556 may define respective holes 2550, 2552 at the pivot point 2516, e.g., for receiving a pivot pin (not shown). As illustrated in FIG. 32, the shuttle 2520 may ride between the arms 2554, 2556. According to various embodiments, the arms 2554, 2556 may define recesses such as recess 2548 for receiving wire conduits (e.g., conduit 2542 shown in FIG. 25).



FIGS. 34 and 35 illustrate one embodiment of the jaw member 2502 of FIG. 25. As shown, the jaw member 2502 may define a hole 2560a at about the pivot point 2516. For example, the hole 2560a may receive a pivot pin. The perspective shown in FIG. 35 provides a view of the slot 2534b. A surface 2662b may partially or completely surround the slot 2534b. The surface 2562b may receive the flange 2528a of the reciprocating member 2524 as it translates distally. The flange 2528a may exert a force on the surface 2562b, and therefore the jaw member 2502, (flange 2528b may exert a force on the surface 2562a and therefore the jaw member 2504), tending to cause the jaw members 2502, 2504 to the closed position. At its proximal portion, the surface 2562b may define an incline 2564b for receiving the flange 2528a. For example, the incline 2564b may allow the flange 2528a to engage the slot 2534b when the jaws 2502, 2504 are not in a closed or completely closed position. FIGS. 36 and 37 illustrate one embodiment of the jaw member 2504 of FIG. 25. As illustrated, the jaw member 2504 may comprise a hole 2560b, surface 2562a and incline 2564a similar to those of the jaw member 2502 described above.


Referring back to FIGS. 25 through 28, FIG. 25 shows the end effector 2500 with the jaw members 2502, 2504 in an open position. In use, the jaw members 2502, 2504 may be placed around tissue, such as a bodily lumen to be severed and sealed. When the end effector 2500 is properly positioned, the clinician may close the jaw members 2502, 2504 by operating an actuator, such as 113, on the handle 102. This may cause the translating member 2530 to translate proximally, pulling the shuttle 2520 proximally along with the cam pin 2518. This may pull the cam pin 2518 proximally within the cam slots 2510, 2512, causing the jaw members 2502, 2504 to pivot about the pivot point 2516 to the closed position shown in FIG. 27. The clinician may then cause the reciprocating member 2524 to extend distally (e.g., by using the actuator 113 or another actuator at the handle 102). This may cause the reciprocating member 2524 to be received into the respective slots 2534a, 2534b. Flanges 2528a, 2528b may contact surfaces 2562a, 2562b, exerting a force on the jaw members 2502, 2504 tending to further close them, as shown in FIG. 28. The cutting edge 2526 of the reciprocating member 2524 may transect tissue held within the jaws. According to various embodiments, the reciprocating member may be extended distally before the jaw members 2502, 2504 are closed, or completely closed. For example, the flanges 2528a, 2528b may engage the inclines 2564a, 2564b, exerting a force on the jaw members 2502, 2504 tending to close them. In various embodiments, severed tissue within the jaws 2502, 2504 may be sealed, for example, utilizing the electrical energy techniques described herein. To open the jaw members 2502, 2504, the reciprocating member 2524 may be withdrawn proximally from the slots 2534a, 2534b. The shuttle 2520 may be pushed distally, for example, by exerting a distally directed force on the translating member 2530 (e.g., via the handle 102). Distal motion of the shuttle 2520 may cause the cam pin 2518 to slide distally within the cam slots 2510, 2512. This may, in turn force the jaw members 2502, 2504 to the open position. In various surgical situations, this may allow the clinician to dissect or separate tissue with the instrument 100. Allowing the clinician to transect and seal as well as dissect with the same instrument 100 may minimize the number of instrument changes required during an operation, thus reducing time and potentially cost.



FIGS. 38-40 illustrate one embodiment of an end effector 2500′ comprising an overtube 3802 for providing closing force to jaw members 2502, 2504. As illustrated in FIGS. 25-26 and 38-39, the respective cam portions 2508, 2510 of the jaw members 2502, 2504 may protrude away from a longitudinal axis 3806 of the end effector 2500′. As the jaw members 2502, 2504 are closed, as shown in FIGS. 27-28 and 40, the cam portions 2508, 2510 translate towards the axis 3806. According to various embodiments, additional clamping force between the jaw members 2502, 2504 may be obtained by forcing the cam portions 2508, 2510 towards the axis 3806. This may be performed by an overtube 3802. The overtube 3802, like the reciprocating member 2524 and shuttle 2520 may be translatable distally and proximally by the clinician from the handle 102. To close the jaw members 2502, 2504, the shuttle 2520 may be translated proximally, causing the jaw members 2502, 2504 to pivot towards the axis 3806, as illustrated and described with reference to FIGS. 27-28. Overtube 3802 may then be translated distally, where it may contact the cam portions 2508, 2506, tending to force them and their respective jaw members 2502, 2504 towards the longitudinal axis 3806. This may provide additional clamping force tending to force the jaw members 2502, 2504 together towards the longitudinal axis 3806. In some embodiments, the overtube 3802 may be shortened in length to more closely resemble a ring for applications involving flexible shafts. This would be of particular benefit for use in flexible endoscopic applications.


According to various embodiments, the shapes of the cam portions 2506 and 2508 and/or the overtube 3802 may be optimized to reduce the force necessary to force the overtube 3802 distally and/or to increase the compression force put on the jaw members 2502, 2504. For example, the cam portions 2506, 2508 may have curved sections 3810, 3812 positioned to contact the overtube 3802. The curved portions may be shaped to act as a camming surface to guide the overtube 3802 over the cam portions 2506, 2508 and progressively increase the compressive force provided by the overtube 3802 as it is translated distally. In some embodiments, the overtube 3802 may also comprise beveled camming surfaces 3808 around its interior distal edge to also guide the overtube 3802 over the cam portions 2506, 2508 and progressively increase the compressive force provided by the overtube 3802 as it is translated distally. Also, according to various embodiments, it will be appreciated that the end effector 2500′ may utilize a reciprocating member 2524 with flanges 2528a, 2528b, as illustrated in FIGS. 29-31. The flanges 2528a, 2528b may serve, as described, to provide additional compressive force as the reciprocating member 2524 is translated distally. In other various embodiments, a reciprocating member 2520 may be used, as shown in FIG. 39. The reciprocating member 2520 may comprise a sharp leading edge for severing tissue, and may traverse within slots 2534a, 2534b of the respective jaw member 2502, 2504. The member 2520, however, may lack flange members, such as 2528a, 2528b. Accordingly, embodiments comprising a reciprocating member such as the member 2520 may rely on the cam portions 2508, 2506, cam slots 2512, 2510, and overtube 3802 to close the jaw members 2502, 2504 and provide compressive force.


In various surgical settings, it may be desirable to close the jaw members of an end effector without cutting tissue therebetween. In this way, an end effector may be used as a grasper as well as a dissecting/sealing instrument. FIGS. 41-43 illustrate one embodiment of a reciprocating member 4140 that may be used in any of the end effectors 106, 1200, 1500, 2000, 2300, 2500, 2500′ described above in order to allow closure of jaw members without the advancement of a blade. The member 4140 may comprise an I-beam member 4102 and a blade member 4104 positioned within the I-beam member. The I-beam member 4102 may comprise a transverse portion 4145 and a pair of flange portions 4144A, 4144B, for example, similar to those of reciprocating members described herein above. According to various embodiments, the I-beam member 4102 may also define a recess 4106 beginning at its distal end. The blade member 4104 may comprise a distally positioned leading edge or blade 4146. In use, the blade member 4104 and I-beam member 4102 may be separately slidable within the shaft 104 (not shown in FIG. 41). Each member 4104, 4102 may be separately controllable from the handle 102. For example, each member 4104, 4102 may be controllable from a separate motion of an actuator 113 or actuators such as a trigger, a slide, etc.


To close an end effector, the I-beam member 4102 may be pushed distally. The flange portions 4144A, 4144B may act to close and compress jaw member portions, for example, as illustrated and described with respect to FIGS. 7-8, 15-18, 20, 22 and 23-24, etc. Because of the recess 4106, tissue or other material present between jaw members may not impede distal motion of the I-beam member 4102. If the clinician decides to transect tissue or other material present between the end effector's jaw members, the clinician may cause the blade member 4104 to extend distally to the position illustrated in FIG. 42 (e.g., by actuating a handle 113 of the handle 102). The sharp leading edge 4146 (or alternatively a cutting electrode) of the blade member 4140 may transect tissue or other material as the blade member 4140 translates distally. According to various embodiments, the blade member 4104 and the I-beam member 4102 may be extended distally together, causing the reciprocating member 4140 to behave in a manner similar to the various reciprocating members described above.


According to various embodiments, the end effectors 106, 1200, 1500, 2000, 2300, 2500, 2500′ may be used to cut and fasten tissue utilizing electrical energy. The examples described below are illustrated with the end effector 106. It will be appreciated, however, that similar configurations and techniques may be used with any of the end effectors described above. Referring to the end effector 106 shown in FIGS. 3-4 and 7-8, the electrodes 120, 122 of the end effector 106 may be arranged in any suitable configuration. In use, for example, tissue (not shown) may be captured between the jaw members 108, 110. RF current may flow across the captured tissue between the opposing polarity electrodes 120, 122. This may serve to join the tissue by coagulation, welding, etc. The RF current may be activated according to any suitable control method. For example, according to various embodiments, the electrodes 120, 122 may be used to implement a “power adjustment” approach, a “current-path directing” approach or an approach referred to herein as a “weld” or “fusion” approach. These various approaches are illustrated herein with reference to FIGS. 44-47, which show the walls of an example blood vessel acted upon by various RF end effectors including those using the power adjustment and current-path directing approaches from above.



FIG. 44 shows an example embodiment of a vessel having opposing wall portions 2a and 2b. FIG. 45 is a graphic illustration of one embodiment of the opposing vessel walls portions 2a and 2b with the tissue divided into a grid with arbitrary micron dimensions. For example, the grid may represent 5 microns on each side of the targeted tissue. In order to coagulate or weld tissue, collagen and other protein molecules within an engaged tissue volume may be denatured by breaking the inter- and intra-molecular hydrogen bonds. When heat or other energy is removed (e.g., thermal relaxation), the molecules are re-crosslinked to create a fused-together tissue mass. It is desirable that each micron-dimensioned volume of tissue be elevated to the temperature needed to denature the proteins therein in a substantially uniform manner.


Failing to heat tissue portions in a uniform manner can lead to ohmic heating, which can create portions of tissue that are not effectively joined and reduce the strength of the joint. Non-uniformly denatured tissue volume may still be “coagulated” and can prevent blood flow in small vasculature that contains little pressure. However, such non-uniformly denatured tissue may not create a seal with significant strength, for example in 2 mm to 10 mm arteries that contain high pressures. It is often difficult to achieve substantially uniform heating with a bipolar RF device in tissue, whether the tissue is thin or thick. For example, as RF energy density in tissue increases, the tissue surface tends to become desiccated and resistant to additional ohmic heating. Localized tissue desiccation and charring can sometimes occur almost instantly as tissue impedance rises, which then can result in a non-uniform seal in the tissue. Also, many RF jaws cause further undesirable effects by propagating RF density laterally from the engaged tissue thus causing unwanted collateral thermal damage.


To achieve substantially uniform coagulation, various embodiments described herein may utilize a “power adjustment” approach, a “current-path directing” approach and/or an approach referred to herein as a “weld” or “fusion” approach. According to the “power adjustment” approach, the RF generator 124 can rapidly adjust the level of total power delivered to the jaws' engagement surfaces in response to feedback circuitry, which may be present within the generator 124 and/or at the end effector 106, and may be electrically coupled to the active electrodes. The feedback circuitry may measure tissue impedance or electrode temperature. For example, temperature probes present on the jaw members 109, 110, 1202, 1204 may be in communication with the generator 123 and may sense electrode temperature. FIG. 46 illustrates one embodiment of the blood vessel of FIG. 44 acted upon by a device implementing a “power adjustment” approach to energy delivery. Opposing vessel walls 2a and 2b are shown compressed with cut-away phantom views of opposing polarity electrodes 4602, 4604 on either side of the tissue. For example, the electrode 4602 may be positioned on one jaw member 108, 110, while the electrode 4604 may be positioned on the opposite jaw member. One advantage of such an electrode arrangement is that 100% of each jaw engagement surface comprises an “active” conductor of electrical current—thus no tissue is engaged by an insulator which theoretically would cause a dead spot (no ohmic heating) proximate to the insulator.



FIG. 46 also graphically depicts current paths p in the tissue at an arbitrary time interval that can be microseconds (μs) apart. Such current paths p would be random and constantly in flux—along transient most conductive pathways through the tissue between the opposing polarity electrodes. The thickness of the paths is intended to represent the constantly adjusting power levels. Typically, the duration of energy density along any current path p is on the order of microseconds and the thermal relaxation time of tissue is on the order of milliseconds. Instruments using the power adjustment approach may be useful for sealing relatively small vessels with relatively low fluid pressure. This is because, given the spatial distribution of the current paths and the dynamic adjustment of their power levels, it is unlikely that enough random current paths will revisit and maintain each discrete micron-scale tissue volume at the targeted temperature before thermal relaxation. Also, because the hydration of tissue is constantly reduced during ohmic heating—any region of more desiccated tissue will lose its ohmic heating, rendering it unable to be “welded” to adjacent tissue volumes.


In a second “current-path directing” approach, the end effector jaws carry an electrode arrangement in which opposing polarity electrodes are spaced apart by an insulator material, which may cause current to flow within an extended path through captured tissue rather than simply between surfaces of the first and second jaws. For example, electrode configurations similar to those shown below in FIG. 47 may be implemented on tissue engaging surfaces 350a, 350b, 1236a, 1236b.


“Current-path directing” techniques are also used to improve the quality of energy-delivered seals. FIG. 47 illustrates one embodiment of the blood vessel of FIG. 44 acted upon by a device implementing a current-path directing approach to energy delivery. In FIG. 47, vessel walls 2a and 2b are engaged between opposing jaws surfaces with cut-away phantom views of electrodes 4702, 4704, 4706, 4708, with opposing polarity (+) and (−) electrodes (4702, 4704 and 4706, 4708) on each side of the engaged tissue. For example, electrodes 4702 and 4704 may be positioned on one of the jaw members 108, 110, 1202, 1204 while electrodes 4706 and 4708 maybe positioned on the opposite jaw member. An insulator 4710 is shown in cut-away view that electrically isolates the electrodes in the jaw. The tissue that directly contacts the insulator 4710 will only be ohmically heated when a current path p extends through the tissue between the spaced apart electrodes. FIG. 47 graphically depicts current paths p at any arbitrary time interval, for example in the μs range. Again, such current paths p will be random and in constant flux along transient conductive pathways.


A third approach, according to various embodiments, may be referred to as a “weld” or “fusion” approach. The alternative terms of tissue “welding” and tissue “fusion” are used interchangeably herein to describe thermal treatments of a targeted tissue volume that result in a substantially uniform fused-together tissue mass, for example in welding blood vessels that exhibit substantial burst strength immediately post-treatment. Such welds may be used in various surgical applications including, for example, (i) permanently sealing blood vessels in vessel transection procedures; (ii) welding organ margins in resection procedures; (iii) welding other anatomic ducts or lumens where permanent closure is desired; and also (iv) for performing vessel anastomosis, vessel closure or other procedures that join together anatomic structures or portions thereof.


The welding or fusion of tissue as disclosed herein may be distinguished from “coagulation”, “hemostasis” and other similar descriptive terms that generally relate to the collapse and occlusion of blood flow within small blood vessels or vascularized tissue. For example, any surface application of thermal energy can cause coagulation or hemostasis—but does not fall into the category of “welding” as the term is used herein. Such surface coagulation does not create a weld that provides any substantial strength in the treated tissue.


A “weld,” for example, may result from the thermally-induced denaturation of collagen and other protein molecules in a targeted tissue volume to create a transient liquid or gel-like proteinaceous amalgam. A selected energy density may be provided in the targeted tissue to cause hydrothermal breakdown of intra- and intermolecular hydrogen crosslinks in collagen and other proteins. The denatured amalgam is maintained at a selected level of hydration—without desiccation—for a selected time interval, which may be very brief. The targeted tissue volume may be maintained under a selected very high level of mechanical compression to insure that the unwound strands of the denatured proteins are in close proximity to allow their intertwining and entanglement. Upon thermal relaxation, the intermixed amalgam results in protein entanglement as re-crosslinking or renaturation occurs to thereby cause a uniform fused-together mass.


To implement the welding described above, the electrodes 120, 122 (or electrodes that are part of the other end effector embodiments described herein) may, one or both, comprise an electrically conductive portion, such as copper or another suitable metal or alloy, and a portion comprising a positive temperature coefficient (PTC) material having a selected increased resistance that differs at selected increased temperatures thereof. The PTC material may be positioned between the electrically conductive portion and any tissue to be acted upon by the end effector 106. One type of PTC material is a ceramic that can be engineered to exhibit a selected positively slope curve of temperature-resistance over a temperature range of about 37° C. to 100° C. Another type of PCT material may comprise a polymer having similar properties. The region at the higher end of such a temperature range brackets a targeted “thermal treatment range” at which tissue can be effectively welded. The selected resistance of the PTC matrix at the upper end of the temperature range may substantially terminate current flow therethrough.


In operation, it can be understood that the electrodes 120 or 122 will apply active RF energy (ohmic heating within) to the engaged tissue until the point in time that the PTC matrix is heated to exceed the maximum of the thermal treatment range. Thereafter, RF current flow from the engagement surface will be lessened—depending on the relative surface areas of the first and second electrodes 120, 122. This instant and automatic reduction of RF energy application may prevent any substantial dehydration of tissue proximate to the engagement plane. By thus maintaining an optimal level of moisture around the engagement plane, the working end can more effectively apply energy to the tissue—and provide a weld thicker tissues with limited collateral thermal effects.


In various embodiments, surgical instruments utilizing various embodiments of the transection and sealing instrument 100, with the various end effectors and actuating mechanisms described herein may be employed in conjunction with a flexible endoscope. FIG. 48 illustrates one embodiment of an endoscope 4814 (illustrated here as a gastroscope) inserted into the upper gastrointestinal tract of a patient. The endoscope 4814 may be any suitable endoscope including, for example, the GIF-100 model available from Olympus Corporation. The endoscope 4814 has a distal end 4816 that may include various optical channels, illumination channels, and working channels. According to various embodiments, the endoscope 4814 may be a flexible endoscope.



FIG. 49 illustrates one embodiment of a distal portion 4816 of the endoscope 4814, which may be used with the transection and sealing instrument 100 described herein. The example endoscope 4814 shown comprises a distal face 4804, which defines the distal ends of illumination channels 4808, an optical channel 4806 and a working channel 4810. The illumination channels 4808 may comprise one or more optical fibers or other suitable waveguides for directing light from a proximally positioned light source (not shown) to the surgical site. The optical channel 4806 may comprise one or more optical fibers or other suitable waveguides for receiving and transmitting an image of the surgical site proximally to a position where the image may be viewed by the clinician operating the endoscope 4814. As described above, the working channel 4810 may allow the clinician to introduce one or more surgical tools to the surgical site. Examples of such surgical tools include scissors, cautery knives, suturing devices, and dissectors. It will be appreciated that the endoscope 4814 is but one example of an endoscope that may be used in accordance with various embodiments. Endoscopes having alternate configurations of optical channels 4806, illumination channels 4808 and/or working channels 4810 may also be used. According to various embodiments, the endoscope 4814 may be, or may be used in conjunction with, steerable devices such as traditional flexible endoscopes or steerable overtubes as described in U.S. Pat. No. 8,262,563, incorporated herein by reference. Combinations of flexible endoscopes and steerable overtubes may also be used in some embodiments.


In at least one such embodiment, the endoscope 4814, a laparoscope, or a thoracoscope, for example, may be introduced into the patient trans-anally through the colon, the abdomen via an incision or keyhole and a trocar, or trans-orally through the esophagus or trans-vaginally through the cervix, for example. These devices may assist the clinician to guide and position the transection and sealing instrument 100 near the tissue treatment region to treat diseased tissue on organs such as the liver, for example.


In one embodiment, Natural Orifice Translumenal Endoscopic Surgery (NOTES)™ techniques may be employed to introduce the endoscope 4814 and various instruments into the patient and carry out the various procedures described herein. A NOTES™ technique is a minimally invasive therapeutic procedure that may be employed to treat diseased tissue or perform other therapeutic operations through a natural opening of the patient without making incisions in the abdomen. A natural opening may be the mouth, anus, and/or vagina. Medical implantable instruments may be introduced into the patient to the target area via the natural opening. In a NOTES™ technique, a clinician inserts a flexible endoscope into one or more natural openings of the patient to view the target area, for example, using a camera. During endoscopic surgery, the clinician inserts surgical devices through one or more lumens or working channels of the endoscope 4814 to perform various key surgical activities (KSA). These KSAs include forming an anastomosis between organs, performing dissections, repairing ulcers and other wounds. Although the devices and methods described herein may be used with NOTES™ techniques, it will be appreciated that they may also be used with other surgical techniques including, for example, other endoscopic techniques, and laparoscopic techniques.


It will be appreciated that the terms “proximal” and “distal” are used herein with reference to a clinician manipulating an end of an instrument extending from the clinician to a surgical site (e.g., through a trocar, through a natural orifice or through an open surgical site). The term “proximal” refers to the portion closest to the clinician, and the term “distal” refers to the portion located away from the clinician. It will be further appreciated that for conciseness and clarity, spatial terms such as “vertical,” “horizontal,” “up,” and “down” may be used herein with respect to the drawings. However, surgical instruments are used in many orientations and positions, and these terms are not intended to be limiting and absolute.


While several embodiments have been illustrated and described, and while several illustrative embodiments have been described in considerable detail, the described embodiments are not intended to restrict or in any way limit the scope of the appended claims to such detail. Additional advantages and modifications may readily appear to those skilled in the art. Those of ordinary skill in the art will readily appreciate the different advantages provided by these various embodiments.


While several embodiments have been described, it should be apparent, however, that various modifications, alterations and adaptations to those embodiments may occur to persons skilled in the art with the attainment of some or all of the advantages of the embodiments. For example, according to various embodiments, a single component may be replaced by multiple components, and multiple components may be replaced by a single component, to perform a given function or functions. The described embodiments are therefore intended to cover all such modifications, alterations and adaptations without departing from the scope of the appended claims.


Various embodiments are directed to apparatuses, systems, and methods for the treatment of tissue. Numerous specific details are set forth to provide a thorough understanding of the overall structure, function, manufacture, and use of the embodiments as described in the specification and illustrated in the accompanying drawings. It will be understood by those skilled in the art, however, that the embodiments may be practiced without such specific details. In other instances, well-known operations, components, and elements have not been described in detail so as not to obscure the embodiments described in the specification. Those of ordinary skill in the art will understand that the embodiments described and illustrated herein are non-limiting examples, and thus it can be appreciated that the specific structural and functional details disclosed herein may be representative and illustrative. Variations and changes thereto may be made without departing from the scope of the claims.


Reference throughout the specification to “various embodiments,” “some embodiments,” “one embodiment,” or “an embodiment”, or the like, means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment. Thus, appearances of the phrases “in various embodiments,” “in some embodiments,” “in one embodiment,” or “in an embodiment”, or the like, in places throughout the specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures, or characteristics may be combined in any suitable manner in one or more embodiments. Thus, the particular features, structures, or characteristics illustrated or described in connection with one embodiment may be combined, in whole or in part, with the features structures, or characteristics of one or more other embodiments without limitation.


The entire disclosures of the following non-provisional United States patents are hereby incorporated by reference herein:

    • U.S. Pat. No. 7,381,209, entitled ELECTROSURGICAL INSTRUMENT;
    • U.S. Pat. No. 7,354,440, entitled ELECTROSURGICAL INSTRUMENT AND METHOD OF USE;
    • U.S. Pat. No. 7,311,709, entitled ELECTROSURGICAL INSTRUMENT AND METHOD OF USE;
    • U.S. Pat. No. 7,309,849, entitled POLYMER COMPOSITIONS EXHIBITING A PTC PROPERTY AND METHODS OF FABRICATION;
    • U.S. Pat. No. 7,220,951, entitled SURGICAL SEALING SURFACES AND METHODS OF USE;
    • U.S. Pat. No. 7,189,233, entitled ELECTROSURGICAL INSTRUMENT; U.S. Pat. No. 7,186,253, entitled ELECTROSURGICAL JAW STRUCTURE FOR CONTROLLED ENERGY DELIVERY;
    • U.S. Pat. No. 7,169,146, entitled ELECTROSURGICAL PROBE AND METHOD OF USE;
    • U.S. Pat. No. 7,125,409, entitled ELECTROSURGICAL WORKING END FOR CONTROLLED ENERGY DELIVERY;
    • U.S. Pat. No. 7,112,201, entitled ELECTROSURGICAL INSTRUMENT AND METHOD OF USE;
    • U.S. Pat. No. 8,262,563, entitled ENDOSCOPIC TRANSLUMENAL ARTICULATABLE STEERABLE OVERTUBE; and
    • U.S. Pat. No. 7,641,671, entitled CLOSING ASSEMBLIES FOR CLAMPING DEVICE.


Any patent, publication, or other disclosure material, in whole or in part, that is said to be incorporated by reference herein is incorporated herein only to the extent that the incorporated material does not conflict with existing definitions, statements or other disclosure material set forth in this disclosure. As such, and to the extent necessary, the disclosure as explicitly set forth herein supersedes any conflicting material incorporated herein by reference. Any material, or portion thereof, that is said to be incorporated by reference herein, but which conflicts with existing definitions, statements, or other disclosure material set forth herein will only be incorporated to the extent that no conflict arises between that incorporated material and the existing disclosure material.


The devices disclosed herein may be designed to be disposed of after a single use, or they may be designed to be used multiple times. In either case, however, the device may be reconditioned for reuse after at least one use. Reconditioning may include a combination of the steps of disassembly of the device, followed by cleaning or replacement of particular pieces, and subsequent reassembly. In particular, the device may be disassembled, and any number of particular pieces or parts of the device may be selectively replaced or removed in any combination. Upon cleaning and/or replacement of particular parts, the device may be reassembled for subsequent use either at a reconditioning facility, or by a surgical team immediately prior to a surgical procedure. Those of ordinary skill in the art will appreciate that the reconditioning of a device may utilize a variety of different techniques for disassembly, cleaning/replacement, and reassembly. Use of such techniques, and the resulting reconditioned device, are all within the scope of this application.


Preferably, the embodiments described herein will be processed before surgery. First a new or used instrument is obtained and, if necessary, cleaned. The instrument may then be sterilized. In one sterilization technique, the instrument is placed in a closed and sealed container, such as a plastic or TYVEK® bag. The container and instrument are then placed in a field of radiation that may penetrate the container, such as gamma radiation, x-rays, or higher energy electrons. The radiation kills bacteria on the instrument and in the container. The sterilized instrument may then be stored in the sterile container. The sealed container keeps the instrument sterile until it is opened in the medical facility.


The embodiments are not to be construed as limited to the particular embodiments disclosed. The embodiments are therefore to be regarded as illustrative rather than restrictive. Variations and changes may be made by others without departing from the scope of the claims. Accordingly, it is expressly intended that all such equivalents, variations and changes that fall within the scope of the claims be embraced thereby.


In summary, numerous benefits have been described which result from employing the embodiments described herein. The foregoing description of the one or more embodiments has been presented for purposes of illustration and description. It is not intended to be exhaustive or limiting to the precise form disclosed. Modifications or variations are possible in light of the above teachings. The one or more embodiments were chosen and described in order to illustrate principles and practical applications to thereby enable one of ordinary skill in the art to utilize the various embodiments and with various modifications as are suited to the particular use contemplated. It is intended that the claims submitted herewith define the overall scope.

Claims
  • 1. A surgical instrument comprising: an end effector comprising: a first jaw member defining a first longitudinal slot;a second jaw member defining a second longitudinal slot, the second jaw member pivotable towards the first jaw member about a pivot point; anda cam pin coupled to the second jaw member and positioned offset from the pivot point; anda reciprocating member translatable distally and proximally through the first longitudinal slot and the second longitudinal slot, wherein a distal portion of the reciprocating member defines a blade, wherein the reciprocating member defines a cam slot for receiving the cam pin, wherein distal motion of the reciprocating member exerts a force on the cam pin to pivot the second jaw member towards the first jaw member, and wherein proximal motion of the reciprocating member exerts a force on the cam pin to pivot the second jaw member away from the first jaw member;wherein the cam slot comprises a distal portion, a proximal portion vertically offset from the distal portion, and a transition portion connecting the distal portion of the cam slot and the proximal portion, the transition portion angled relative to a longitudinal axis along which the reciprocating member is translatable.
  • 2. The surgical instrument of claim 1, further comprising a shaft extending along a longitudinal axis, wherein the end effector is coupled to a distal portion of the shaft.
  • 3. The surgical instrument of claim 2, wherein the first jaw member is stationary and coupled to the shaft.
  • 4. The surgical instrument of claim 1, wherein the first jaw member is pivotable towards the second jaw member about the pivot point and comprises a first jaw member cam pin, wherein the reciprocating member also defines a second cam slot for receiving the first jaw member cam pin, wherein the distal motion of the reciprocating member exerts a force on the first jaw member cam pin to pivot the first jaw member towards the second jaw member, and wherein the proximal motion of the reciprocating member exerts a force on the first jaw member to pivot the first jaw member away from the second jaw member.
  • 5. The surgical instrument of claim 1, wherein the pivot point is a rolling pivot point.
  • 6. The surgical instrument of claim 1, wherein the distal portion of the cam slot is positioned near a bottom of the reciprocating member, and wherein the transition portion is positioned between the distal portion of the cam slot and the proximal portion.
  • 7. The surgical instrument of claim 1, wherein the reciprocating member comprises a pair of flanges positioned to ride above the first and second longitudinal slots when the reciprocating member is extended distally through the first and second longitudinal slots.
  • 8. The surgical instrument of claim 1, wherein the first jaw member further comprises a first electrode and the second jaw member further comprises a second electrode.
  • 9. The surgical instrument of claim 8, wherein at least one of the first electrode and the second electrode comprises a first electrically conductive portion and a positive temperature coefficient (PTC) portion.
  • 10. The surgical instrument of claim 9, wherein the PTC portion comprises a PTC material with a temperature dependent electrical resistance such that the electrical resistance of the PTC material increases to substantially eliminate current flowing through the PTC material at a predetermined temperature.
  • 11. The surgical instrument of claim 1, wherein the first jaw member comprises a tissue engagement surface comprising a positive electrode and a negative electrode separated by an insulator.
PRIORITY CLAIM

The present application is a continuation of U.S. patent application Ser. No. 12/758,253, now U.S. Pat. No. 8,834,518, filed on Apr. 12, 2010 and published as US2011/0251612, which is incorporated herein by reference in its entirety.

US Referenced Citations (848)
Number Name Date Kind
2366274 Luth et al. Jan 1945 A
2458152 Eakins Jan 1949 A
2510693 Green Jun 1950 A
2867039 Zach Jan 1959 A
3166971 Stoecker Jan 1965 A
3525912 Wallin Aug 1970 A
3580841 Cadotte et al. May 1971 A
3703651 Blowers Nov 1972 A
3777760 Essner Dec 1973 A
4005714 Hiltebrandt Feb 1977 A
4034762 Cosens et al. Jul 1977 A
4058126 Leveen Nov 1977 A
4203430 Takahashi May 1980 A
4220154 Semm Sep 1980 A
4237441 van Konynenburg et al. Dec 1980 A
4281785 Brooks Aug 1981 A
4304987 van Konynenburg Dec 1981 A
4314559 Allen Feb 1982 A
4463759 Garito et al. Aug 1984 A
4492231 Auth Jan 1985 A
4535773 Yoon Aug 1985 A
4545926 Fouts, Jr. et al. Oct 1985 A
4550870 Krumme et al. Nov 1985 A
4582236 Hirose Apr 1986 A
4617927 Manes Oct 1986 A
4735603 Goodson et al. Apr 1988 A
4761871 O'Connor et al. Aug 1988 A
4830462 Karny et al. May 1989 A
4849133 Yoshida et al. Jul 1989 A
4860745 Farin et al. Aug 1989 A
4878493 Pasternak et al. Nov 1989 A
4880015 Nierman Nov 1989 A
4910389 Sherman et al. Mar 1990 A
4920978 Colvin May 1990 A
4936842 D'Amelio et al. Jun 1990 A
5020514 Heckele Jun 1991 A
5061269 Muller Oct 1991 A
5099840 Goble et al. Mar 1992 A
5104025 Main et al. Apr 1992 A
5106538 Barma et al. Apr 1992 A
5108383 White Apr 1992 A
5156633 Smith Oct 1992 A
5160334 Billings et al. Nov 1992 A
5190541 Abele et al. Mar 1993 A
5196007 Ellman et al. Mar 1993 A
5205459 Brinkerhoff et al. Apr 1993 A
5217460 Knoepfler Jun 1993 A
5234428 Kaufman Aug 1993 A
5258006 Rydell et al. Nov 1993 A
5285945 Brinkerhoff et al. Feb 1994 A
5290286 Parins Mar 1994 A
5309927 Welch May 1994 A
5312023 Green et al. May 1994 A
5318563 Malis et al. Jun 1994 A
5318564 Eggers Jun 1994 A
5318589 Lichtman Jun 1994 A
5326013 Green et al. Jul 1994 A
5330471 Eggers Jul 1994 A
5330502 Hassler et al. Jul 1994 A
5339723 Huitema Aug 1994 A
5342359 Rydell Aug 1994 A
5361583 Huitema Nov 1994 A
5383874 Jackson et al. Jan 1995 A
5387207 Dyer et al. Feb 1995 A
5389098 Tsuruta et al. Feb 1995 A
5395312 Desai Mar 1995 A
5395363 Billings et al. Mar 1995 A
5395364 Anderhub et al. Mar 1995 A
5396266 Brimhall Mar 1995 A
5396900 Slater et al. Mar 1995 A
5403312 Yates et al. Apr 1995 A
5417709 Slater May 1995 A
5428504 Bhatla Jun 1995 A
5429131 Scheinman et al. Jul 1995 A
5443463 Stern et al. Aug 1995 A
5445638 Rydell et al. Aug 1995 A
5451227 Michaelson Sep 1995 A
5456684 Schmidt et al. Oct 1995 A
5458598 Feinberg et al. Oct 1995 A
5465895 Knodel et al. Nov 1995 A
5472443 Cordis et al. Dec 1995 A
5476479 Green et al. Dec 1995 A
5478003 Green et al. Dec 1995 A
5480409 Riza Jan 1996 A
5484436 Eggers et al. Jan 1996 A
5486189 Mudry et al. Jan 1996 A
5496317 Goble et al. Mar 1996 A
5504650 Katsui et al. Apr 1996 A
5509922 Aranyi et al. Apr 1996 A
5511556 DeSantis Apr 1996 A
5520704 Castro et al. May 1996 A
5522839 Pilling Jun 1996 A
5531744 Nardella et al. Jul 1996 A
5540681 Strul et al. Jul 1996 A
5542916 Hirsch et al. Aug 1996 A
5558671 Yates Sep 1996 A
5563179 Stone et al. Oct 1996 A
5569164 Lurz Oct 1996 A
5571121 Heifetz Nov 1996 A
5573534 Stone Nov 1996 A
5584830 Ladd et al. Dec 1996 A
5599350 Schulze et al. Feb 1997 A
5607450 Zvenyatsky et al. Mar 1997 A
5611813 Lichtman Mar 1997 A
5618307 Donlon et al. Apr 1997 A
5624452 Yates Apr 1997 A
5632432 Schulze et al. May 1997 A
5647871 Levine et al. Jul 1997 A
5658281 Heard Aug 1997 A
5662667 Knodel Sep 1997 A
5665085 Nardella Sep 1997 A
5665100 Yoon Sep 1997 A
5674219 Monson et al. Oct 1997 A
5674220 Fox et al. Oct 1997 A
5688270 Yates et al. Nov 1997 A
5693051 Schulze et al. Dec 1997 A
5709680 Yates et al. Jan 1998 A
5711472 Bryan Jan 1998 A
5713896 Nardella Feb 1998 A
5716366 Yates Feb 1998 A
5720742 Zacharias Feb 1998 A
5720744 Eggleston et al. Feb 1998 A
5735848 Yates et al. Apr 1998 A
5743906 Parins et al. Apr 1998 A
5752973 Kieturakis May 1998 A
5755717 Yates et al. May 1998 A
5762255 Chrisman et al. Jun 1998 A
5779701 McBrayer et al. Jul 1998 A
5782834 Lucey et al. Jul 1998 A
5792135 Madhani et al. Aug 1998 A
5792138 Shipp Aug 1998 A
5796188 Bays Aug 1998 A
5797941 Schulze et al. Aug 1998 A
5800432 Swanson Sep 1998 A
5800449 Wales Sep 1998 A
5805140 Rosenberg et al. Sep 1998 A
5807393 Williamson, IV et al. Sep 1998 A
5810811 Yates et al. Sep 1998 A
5817033 DeSantis et al. Oct 1998 A
5817084 Jensen Oct 1998 A
5817093 Williamson, IV et al. Oct 1998 A
5827323 Klieman Oct 1998 A
5836909 Cosmescu Nov 1998 A
5836943 Miller, III Nov 1998 A
5836990 Li Nov 1998 A
5853412 Mayenberger Dec 1998 A
5876401 Schulze et al. Mar 1999 A
5878193 Wang et al. Mar 1999 A
5880668 Hall Mar 1999 A
5891142 Eggers et al. Apr 1999 A
5906625 Bito et al. May 1999 A
5910129 Koblish et al. Jun 1999 A
5921956 Grinberg et al. Jul 1999 A
5929846 Rosenberg et al. Jul 1999 A
5984938 Yoon Nov 1999 A
6003517 Sheffield et al. Dec 1999 A
6013052 Durman et al. Jan 2000 A
6024741 Williamson, IV et al. Feb 2000 A
6024744 Kese et al. Feb 2000 A
6033399 Gines Mar 2000 A
6039734 Goble Mar 2000 A
6050996 Schmaltz et al. Apr 2000 A
6063098 Houser et al. May 2000 A
6068629 Haissaguerre et al. May 2000 A
6074389 Levine et al. Jun 2000 A
6091995 Ingle et al. Jul 2000 A
6099483 Palmer et al. Aug 2000 A
6099550 Yoon Aug 2000 A
H1904 Yates et al. Oct 2000 H
6132368 Cooper Oct 2000 A
6144402 Norsworthy et al. Nov 2000 A
6152923 Ryan Nov 2000 A
6154198 Rosenberg Nov 2000 A
6162208 Hipps Dec 2000 A
6174309 Wrublewski et al. Jan 2001 B1
6176857 Ashley Jan 2001 B1
6190386 Rydell Feb 2001 B1
6206876 Levine et al. Mar 2001 B1
6228080 Gines May 2001 B1
6231565 Tovey et al. May 2001 B1
6259230 Chou Jul 2001 B1
6277117 Tetzlaff et al. Aug 2001 B1
6292700 Morrison et al. Sep 2001 B1
6325799 Goble Dec 2001 B1
6340878 Oglesbee Jan 2002 B1
6364888 Niemeyer et al. Apr 2002 B1
6387109 Davison et al. May 2002 B1
6391026 Hung et al. May 2002 B1
6398779 Buysse et al. Jun 2002 B1
6409722 Hoey et al. Jun 2002 B1
H2037 Yates et al. Jul 2002 H
6419675 Gallo, Sr. Jul 2002 B1
6430446 Knowlton Aug 2002 B1
6443968 Holthaus et al. Sep 2002 B1
6458128 Schulze Oct 2002 B1
6464689 Qin et al. Oct 2002 B1
6464702 Schulze et al. Oct 2002 B2
6480796 Wiener Nov 2002 B2
6491690 Goble et al. Dec 2002 B1
6500112 Khouri Dec 2002 B1
6500176 Truckai Dec 2002 B1
6503248 Levine Jan 2003 B1
6511480 Tetzlaff et al. Jan 2003 B1
6514252 Nezhat et al. Feb 2003 B2
6517565 Whitman et al. Feb 2003 B1
6531846 Smith Mar 2003 B1
6533784 Truckai et al. Mar 2003 B2
6537272 Christopherson et al. Mar 2003 B2
6537291 Friedman et al. Mar 2003 B2
6551309 LePivert Apr 2003 B1
6554829 Schulze et al. Apr 2003 B2
6558376 Bishop May 2003 B2
6562037 Paton et al. May 2003 B2
6572639 Ingle et al. Jun 2003 B1
6575969 Rittman, III et al. Jun 2003 B1
6582451 Marucci et al. Jun 2003 B1
6584360 Francischelli et al. Jun 2003 B2
6585735 Frazier et al. Jul 2003 B1
6589200 Schwemberger et al. Jul 2003 B1
6602252 Mollenauer Aug 2003 B2
6610060 Mulier et al. Aug 2003 B2
6619529 Green et al. Sep 2003 B2
6620161 Schulze et al. Sep 2003 B2
6622731 Daniel et al. Sep 2003 B2
6623482 Pendekanti et al. Sep 2003 B2
6635057 Harano et al. Oct 2003 B2
6644532 Green et al. Nov 2003 B2
6651669 Burnside Nov 2003 B1
6656177 Truckai Dec 2003 B2
6656198 Tsonton et al. Dec 2003 B2
6662127 Wiener et al. Dec 2003 B2
6673248 Chowdhury Jan 2004 B2
6679882 Kornerup Jan 2004 B1
6682501 Nelson et al. Jan 2004 B1
6695840 Schulze Feb 2004 B2
6722552 Fenton, Jr. Apr 2004 B2
6733498 Paton et al. May 2004 B2
6746443 Morley et al. Jun 2004 B1
6752815 Beaupre Jun 2004 B2
6766202 Underwood et al. Jul 2004 B2
6770072 Truckai et al. Aug 2004 B1
6773409 Truckai et al. Aug 2004 B2
6773435 Schulze et al. Aug 2004 B2
6775575 Bommannan et al. Aug 2004 B2
6783524 Anderson et al. Aug 2004 B2
6789939 Schrödinger et al. Sep 2004 B2
6796981 Wham et al. Sep 2004 B2
6800085 Selmon et al. Oct 2004 B2
6802843 Truckai et al. Oct 2004 B2
6811842 Ehrnsperger et al. Nov 2004 B1
6821273 Mollenauer Nov 2004 B2
6835199 McGuckin, Jr. et al. Dec 2004 B2
6840938 Morley et al. Jan 2005 B1
6860880 Treat et al. Mar 2005 B2
6877647 Green et al. Apr 2005 B2
6893435 Goble May 2005 B2
6905497 Truckai et al. Jun 2005 B2
6908463 Treat et al. Jun 2005 B2
6913579 Truckai et al. Jul 2005 B2
6926716 Baker et al. Aug 2005 B2
6929622 Chian Aug 2005 B2
6929644 Truckai et al. Aug 2005 B2
6953461 McClurken et al. Oct 2005 B2
6977495 Donofrio Dec 2005 B2
6994709 Iida Feb 2006 B2
7000818 Shelton, IV et al. Feb 2006 B2
7011657 Truckai et al. Mar 2006 B2
7041102 Truckai et al. May 2006 B2
7052496 Yamauchi May 2006 B2
7055731 Shelton, IV et al. Jun 2006 B2
7063699 Hess et al. Jun 2006 B2
7066936 Ryan Jun 2006 B2
7070597 Truckai et al. Jul 2006 B2
7077853 Kramer et al. Jul 2006 B2
7083618 Couture et al. Aug 2006 B2
7083619 Truckai et al. Aug 2006 B2
7087054 Truckai et al. Aug 2006 B2
7094235 Francischelli Aug 2006 B2
7101371 Dycus et al. Sep 2006 B2
7101372 Dycus et al. Sep 2006 B2
7101373 Dycus et al. Sep 2006 B2
7112201 Truckai et al. Sep 2006 B2
7118570 Tetzlaff et al. Oct 2006 B2
7125409 Truckai et al. Oct 2006 B2
7131970 Moses et al. Nov 2006 B2
7137980 Buysse et al. Nov 2006 B2
7143925 Shelton, IV et al. Dec 2006 B2
7147138 Shelton, IV Dec 2006 B2
7156846 Dycus et al. Jan 2007 B2
7160296 Pearson et al. Jan 2007 B2
7169146 Truckai et al. Jan 2007 B2
7169156 Hart Jan 2007 B2
7179271 Friedman et al. Feb 2007 B2
7186253 Truckai et al. Mar 2007 B2
7189233 Truckai et al. Mar 2007 B2
7195631 Dumbauld Mar 2007 B2
7207471 Heinrich et al. Apr 2007 B2
7220951 Truckai et al. May 2007 B2
7225964 Mastri et al. Jun 2007 B2
7226448 Bertolero et al. Jun 2007 B2
7232440 Dumbauld et al. Jun 2007 B2
7235073 Levine et al. Jun 2007 B2
7241294 Reschke Jul 2007 B2
7251531 Mosher et al. Jul 2007 B2
7252667 Moses et al. Aug 2007 B2
7255697 Dycus Aug 2007 B2
7267677 Johnson et al. Sep 2007 B2
7267685 Butaric et al. Sep 2007 B2
7273483 Wiener et al. Sep 2007 B2
7287682 Ezzat et al. Oct 2007 B1
7300450 Vleugels et al. Nov 2007 B2
7303557 Wham et al. Dec 2007 B2
7307313 Ohyanagi et al. Dec 2007 B2
7309849 Truckai et al. Dec 2007 B2
7311709 Truckai et al. Dec 2007 B2
7329257 Kanehira et al. Feb 2008 B2
7354440 Truckai et al. Apr 2008 B2
7357287 Shelton, IV et al. Apr 2008 B2
7364577 Wham et al. Apr 2008 B2
7367976 Lawes et al. May 2008 B2
7371227 Zeiner May 2008 B2
RE40388 Gines Jun 2008 E
7381209 Truckai et al. Jun 2008 B2
7384420 Dycus et al. Jun 2008 B2
7396356 Mollenauer Jul 2008 B2
7403224 Fuller et al. Jul 2008 B2
7404508 Smith et al. Jul 2008 B2
7407077 Ortiz et al. Aug 2008 B2
7416101 Shelton, IV et al. Aug 2008 B2
7422139 Shelton, IV et al. Sep 2008 B2
7435582 Zimmermann et al. Oct 2008 B2
7441684 Shelton, IV et al. Oct 2008 B2
7442193 Shields et al. Oct 2008 B2
7445621 Dumbauld et al. Nov 2008 B2
7464846 Shelton, IV et al. Dec 2008 B2
7473253 Dycus et al. Jan 2009 B2
7488319 Yates Feb 2009 B2
7491201 Shields et al. Feb 2009 B2
7494501 Ahlberg et al. Feb 2009 B2
7498080 Tung et al. Mar 2009 B2
7506791 Omaits et al. Mar 2009 B2
7510107 Timm et al. Mar 2009 B2
7513025 Fischer Apr 2009 B2
7517349 Truckai et al. Apr 2009 B2
7524320 Tierney et al. Apr 2009 B2
7540872 Schechter et al. Jun 2009 B2
7543730 Marczyk Jun 2009 B1
7550216 Ofer et al. Jun 2009 B2
7553309 Buysse et al. Jun 2009 B2
7559452 Wales et al. Jul 2009 B2
7582086 Privitera et al. Sep 2009 B2
7586289 Andruk et al. Sep 2009 B2
7588176 Timm et al. Sep 2009 B2
7594925 Danek et al. Sep 2009 B2
7597693 Garrison Oct 2009 B2
7604150 Boudreaux Oct 2009 B2
7621930 Houser Nov 2009 B2
7628791 Garrison et al. Dec 2009 B2
7628792 Guerra Dec 2009 B2
7632267 Dahla Dec 2009 B2
7632269 Truckai et al. Dec 2009 B2
7641653 Dalla Betta et al. Jan 2010 B2
7641671 Crainich Jan 2010 B2
7644848 Swayze et al. Jan 2010 B2
7645277 McClurken et al. Jan 2010 B2
7648499 Orszulak et al. Jan 2010 B2
7658311 Boudreaux Feb 2010 B2
7665647 Shelton, IV et al. Feb 2010 B2
7666206 Taniguchi et al. Feb 2010 B2
7670334 Hueil et al. Mar 2010 B2
7691095 Bednarek et al. Apr 2010 B2
7691098 Wallace et al. Apr 2010 B2
7703459 Saadat et al. Apr 2010 B2
7703653 Shah et al. Apr 2010 B2
7708751 Hughes et al. May 2010 B2
7717915 Miyazawa May 2010 B2
7722527 Bouchier et al. May 2010 B2
7722607 Dumbauld et al. May 2010 B2
7726537 Olson et al. Jun 2010 B2
7753904 Shelton, IV et al. Jul 2010 B2
7753908 Swanson Jul 2010 B2
7762445 Heinrich et al. Jul 2010 B2
7766210 Shelton, IV et al. Aug 2010 B2
7766910 Hixson et al. Aug 2010 B2
7770775 Shelton, IV et al. Aug 2010 B2
7775972 Brock et al. Aug 2010 B2
7776037 Odom Aug 2010 B2
7780651 Madhani et al. Aug 2010 B2
7780663 Yates et al. Aug 2010 B2
7784663 Shelton, IV Aug 2010 B2
7789883 Takashino et al. Sep 2010 B2
7793814 Racenet et al. Sep 2010 B2
7803156 Eder et al. Sep 2010 B2
7806891 Nowlin et al. Oct 2010 B2
7810693 Broehl et al. Oct 2010 B2
7815641 Dodde et al. Oct 2010 B2
7819298 Hall et al. Oct 2010 B2
7819299 Shelton, IV et al. Oct 2010 B2
7819872 Johnson et al. Oct 2010 B2
7824401 Manzo et al. Nov 2010 B2
7832408 Shelton, IV et al. Nov 2010 B2
7832612 Baxter, III et al. Nov 2010 B2
7845537 Shelton, IV et al. Dec 2010 B2
7846159 Morrison et al. Dec 2010 B2
7846160 Payne et al. Dec 2010 B2
7861906 Doll et al. Jan 2011 B2
7879035 Garrison et al. Feb 2011 B2
7879070 Ortiz et al. Feb 2011 B2
7896875 Heim et al. Mar 2011 B2
7901400 Wham et al. Mar 2011 B2
7909220 Viola Mar 2011 B2
7919184 Mohapatra et al. Apr 2011 B2
7922061 Shelton, IV et al. Apr 2011 B2
7922651 Yamada et al. Apr 2011 B2
7931649 Couture et al. Apr 2011 B2
7935114 Takashino et al. May 2011 B2
7951165 Golden et al. May 2011 B2
7955331 Truckai et al. Jun 2011 B2
7963963 Francischelli et al. Jun 2011 B2
7967602 Lindquist Jun 2011 B2
7981113 Truckai et al. Jul 2011 B2
7997278 Utley et al. Aug 2011 B2
8020743 Shelton, IV Sep 2011 B2
8038693 Allen Oct 2011 B2
8056720 Hawkes Nov 2011 B2
8058771 Giordano et al. Nov 2011 B2
8061014 Smith et al. Nov 2011 B2
8070036 Knodel et al. Dec 2011 B1
8105323 Buysse et al. Jan 2012 B2
8128624 Couture et al. Mar 2012 B2
8136712 Zingman Mar 2012 B2
8141762 Bedi et al. Mar 2012 B2
8157145 Shelton, IV et al. Apr 2012 B2
8197472 Lau et al. Jun 2012 B2
8197479 Olson et al. Jun 2012 B2
8197502 Smith et al. Jun 2012 B2
8221415 Francischelli Jul 2012 B2
8236020 Smith et al. Aug 2012 B2
8241235 Kahler et al. Aug 2012 B2
8241284 Dycus et al. Aug 2012 B2
8246615 Behnke Aug 2012 B2
8246618 Bucciaglia et al. Aug 2012 B2
8251994 McKenna et al. Aug 2012 B2
8262563 Bakos et al. Sep 2012 B2
8267300 Boudreaux Sep 2012 B2
8277446 Heard Oct 2012 B2
8277447 Garrison et al. Oct 2012 B2
8282669 Gerber et al. Oct 2012 B2
8287528 Wham et al. Oct 2012 B2
8292886 Kerr et al. Oct 2012 B2
8298232 Unger Oct 2012 B2
8303583 Hosier et al. Nov 2012 B2
8323310 Kingsley Dec 2012 B2
8333778 Smith et al. Dec 2012 B2
8333779 Smith et al. Dec 2012 B2
8334468 Palmer et al. Dec 2012 B2
8338726 Palmer et al. Dec 2012 B2
8357158 McKenna et al. Jan 2013 B2
8372064 Douglass et al. Feb 2013 B2
8372099 Deville et al. Feb 2013 B2
8372101 Smith et al. Feb 2013 B2
8377059 Deville et al. Feb 2013 B2
8377085 Smith et al. Feb 2013 B2
8397971 Yates et al. Mar 2013 B2
8403948 Deville et al. Mar 2013 B2
8403949 Palmer et al. Mar 2013 B2
8403950 Palmer et al. Mar 2013 B2
8414577 Boudreaux et al. Apr 2013 B2
8418349 Smith et al. Apr 2013 B2
8419757 Smith et al. Apr 2013 B2
8419758 Smith et al. Apr 2013 B2
8425545 Smith et al. Apr 2013 B2
8430876 Kappus et al. Apr 2013 B2
8435257 Smith et al. May 2013 B2
8439939 Deville et al. May 2013 B2
8444662 Palmer et al. May 2013 B2
8444664 Balanev et al. May 2013 B2
8453906 Huang et al. Jun 2013 B2
8460288 Tamai et al. Jun 2013 B2
8460292 Truckai et al. Jun 2013 B2
8480703 Nicholas et al. Jul 2013 B2
8485413 Scheib et al. Jul 2013 B2
8486057 Behnke, II Jul 2013 B2
8496682 Guerra et al. Jul 2013 B2
8535311 Schall Sep 2013 B2
8535340 Allen Sep 2013 B2
8535341 Allen Sep 2013 B2
8540128 Shelton, IV et al. Sep 2013 B2
8562598 Falkenstein et al. Oct 2013 B2
8562604 Nishimura Oct 2013 B2
8568390 Mueller Oct 2013 B2
8568412 Brandt et al. Oct 2013 B2
8569997 Lee Oct 2013 B2
8574231 Boudreaux et al. Nov 2013 B2
8591506 Wham et al. Nov 2013 B2
D695407 Price et al. Dec 2013 S
8613383 Beckman et al. Dec 2013 B2
8623011 Spivey Jan 2014 B2
8623016 Fischer Jan 2014 B2
8623027 Price et al. Jan 2014 B2
8623044 Timm et al. Jan 2014 B2
8628529 Aldridge et al. Jan 2014 B2
8632461 Glossop Jan 2014 B2
8638428 Brown Jan 2014 B2
8647350 Mohan et al. Feb 2014 B2
8663220 Wiener et al. Mar 2014 B2
8663222 Anderson et al. Mar 2014 B2
8684253 Giordano et al. Apr 2014 B2
8685020 Weizman et al. Apr 2014 B2
8696665 Hunt et al. Apr 2014 B2
8702609 Hadjicostis Apr 2014 B2
8702704 Shelton, IV et al. Apr 2014 B2
8709035 Johnson et al. Apr 2014 B2
8715270 Weitzner et al. May 2014 B2
8715277 Weizman May 2014 B2
8734443 Hixson et al. May 2014 B2
8747238 Shelton, IV et al. Jun 2014 B2
8747351 Schultz Jun 2014 B2
8747404 Boudreaux et al. Jun 2014 B2
8752264 Ackley et al. Jun 2014 B2
8752749 Moore et al. Jun 2014 B2
8753338 Widenhouse et al. Jun 2014 B2
8764747 Cummings et al. Jul 2014 B2
8790342 Stulen et al. Jul 2014 B2
8795276 Dietz et al. Aug 2014 B2
8795327 Dietz et al. Aug 2014 B2
8827992 Koss et al. Sep 2014 B2
8834466 Cummings et al. Sep 2014 B2
8834518 Faller et al. Sep 2014 B2
8845630 Mehta et al. Sep 2014 B2
8888776 Dietz et al. Nov 2014 B2
8888809 Davison et al. Nov 2014 B2
8906016 Boudreaux et al. Dec 2014 B2
8926607 Norvell et al. Jan 2015 B2
8926608 Bacher et al. Jan 2015 B2
8931682 Timm et al. Jan 2015 B2
8939974 Boudreaux et al. Jan 2015 B2
8951248 Messerly et al. Feb 2015 B2
8956349 Aldridge et al. Feb 2015 B2
8979843 Timm et al. Mar 2015 B2
8979844 White et al. Mar 2015 B2
8979890 Boudreaux Mar 2015 B2
8986302 Aldridge et al. Mar 2015 B2
8992422 Spivey et al. Mar 2015 B2
9005199 Beckman et al. Apr 2015 B2
9011437 Woodruff et al. Apr 2015 B2
9028494 Shelton, IV et al. May 2015 B2
9028519 Yates et al. May 2015 B2
9044243 Johnson et al. Jun 2015 B2
9044256 Cadeddu et al. Jun 2015 B2
9055961 Manzo et al. Jun 2015 B2
9060770 Shelton, IV et al. Jun 2015 B2
9066723 Beller et al. Jun 2015 B2
9072535 Shelton, IV et al. Jul 2015 B2
9072536 Shelton, IV et al. Jul 2015 B2
9101385 Shelton, IV et al. Aug 2015 B2
9119657 Shelton, IV et al. Sep 2015 B2
9125662 Shelton, IV Sep 2015 B2
9149324 Huang et al. Oct 2015 B2
9149325 Worrell et al. Oct 2015 B2
9168085 Juzkiw et al. Oct 2015 B2
9179912 Yates et al. Nov 2015 B2
9192380 Racenet et al. Nov 2015 B2
9192431 Woodruff et al. Nov 2015 B2
9198714 Worrell et al. Dec 2015 B2
9204879 Shelton, IV Dec 2015 B2
9216050 Condie et al. Dec 2015 B2
9226751 Shelton, IV et al. Jan 2016 B2
9226767 Stulen et al. Jan 2016 B2
9237891 Shelton, IV Jan 2016 B2
9259265 Harris et al. Feb 2016 B2
9265926 Strobl et al. Feb 2016 B2
9277962 Koss et al. Mar 2016 B2
9283027 Monson et al. Mar 2016 B2
9283045 Rhee et al. Mar 2016 B2
9295514 Shelton, IV et al. Mar 2016 B2
9314292 Trees et al. Apr 2016 B2
9326788 Batross et al. May 2016 B2
9333025 Monson et al. May 2016 B2
9351754 Vakharia et al. May 2016 B2
9375232 Hunt et al. Jun 2016 B2
9375267 Kerr et al. Jun 2016 B2
9408660 Strobl et al. Aug 2016 B2
9414880 Monson et al. Aug 2016 B2
9421060 Monson et al. Aug 2016 B2
9456863 Moua Oct 2016 B2
9456864 Witt et al. Oct 2016 B2
9510906 Boudreaux et al. Dec 2016 B2
9522029 Yates et al. Dec 2016 B2
20020022836 Goble et al. Feb 2002 A1
20020049551 Friedman et al. Apr 2002 A1
20020107517 Witt et al. Aug 2002 A1
20020165541 Whitman Nov 2002 A1
20030014053 Nguyen et al. Jan 2003 A1
20030105474 Bonutti Jun 2003 A1
20030109875 Tetzlaff et al. Jun 2003 A1
20030114851 Truckai et al. Jun 2003 A1
20030130693 Levin et al. Jul 2003 A1
20030139741 Goble et al. Jul 2003 A1
20030158548 Phan et al. Aug 2003 A1
20030171747 Kanehira et al. Sep 2003 A1
20030216722 Swanson Nov 2003 A1
20030229344 Dycus et al. Dec 2003 A1
20040019350 O'Brien et al. Jan 2004 A1
20040054364 Aranyi et al. Mar 2004 A1
20040092992 Adams et al. May 2004 A1
20040138621 Jahns et al. Jul 2004 A1
20040167508 Wham et al. Aug 2004 A1
20040193148 Wham et al. Sep 2004 A1
20040193150 Sharkey et al. Sep 2004 A1
20040232196 Shelton, IV et al. Nov 2004 A1
20040249374 Tetzlaff et al. Dec 2004 A1
20040260273 Wan Dec 2004 A1
20050015125 Mioduski et al. Jan 2005 A1
20050033278 McClurken et al. Feb 2005 A1
20050085809 Mucko et al. Apr 2005 A1
20050090817 Phan Apr 2005 A1
20050103819 Racenet et al. May 2005 A1
20050131390 Heinrich et al. Jun 2005 A1
20050165429 Douglas et al. Jul 2005 A1
20050171522 Christopherson Aug 2005 A1
20050203507 Truckai et al. Sep 2005 A1
20050256405 Makin et al. Nov 2005 A1
20050261581 Hughes et al. Nov 2005 A1
20050267464 Truckai et al. Dec 2005 A1
20060052778 Chapman et al. Mar 2006 A1
20060058825 Ogura et al. Mar 2006 A1
20060064086 Odom Mar 2006 A1
20060069388 Truckai et al. Mar 2006 A1
20060159731 Shoshan Jul 2006 A1
20060270916 Skwarek et al. Nov 2006 A1
20060293656 Shadduck et al. Dec 2006 A1
20070027469 Smith et al. Feb 2007 A1
20070073185 Nakao Mar 2007 A1
20070073341 Smith et al. Mar 2007 A1
20070106158 Madan et al. May 2007 A1
20070106317 Shelton, IV et al. May 2007 A1
20070118115 Artale et al. May 2007 A1
20070146113 Truckai et al. Jun 2007 A1
20070173803 Wham et al. Jul 2007 A1
20070173811 Couture et al. Jul 2007 A1
20070173813 Odom Jul 2007 A1
20070175949 Shelton, IV et al. Aug 2007 A1
20070185474 Nahen Aug 2007 A1
20070191713 Eichmann et al. Aug 2007 A1
20070191830 Crompton, Jr. et al. Aug 2007 A1
20070203483 Kim et al. Aug 2007 A1
20070208312 Norton et al. Sep 2007 A1
20070208340 Ganz et al. Sep 2007 A1
20070232920 Kowalski et al. Oct 2007 A1
20070232926 Stulen et al. Oct 2007 A1
20070232927 Madan et al. Oct 2007 A1
20070232928 Wiener et al. Oct 2007 A1
20070236213 Paden et al. Oct 2007 A1
20070239025 Wiener et al. Oct 2007 A1
20070260242 Dycus et al. Nov 2007 A1
20070265613 Edelstein et al. Nov 2007 A1
20070265616 Couture et al. Nov 2007 A1
20080015575 Odom et al. Jan 2008 A1
20080071269 Hilario et al. Mar 2008 A1
20080114355 Whayne et al. May 2008 A1
20080147058 Horrell et al. Jun 2008 A1
20080147062 Truckai et al. Jun 2008 A1
20080167522 Giordano et al. Jul 2008 A1
20080188755 Hart Aug 2008 A1
20080188851 Truckai et al. Aug 2008 A1
20080188912 Stone et al. Aug 2008 A1
20080214967 Aranyi et al. Sep 2008 A1
20080221565 Eder et al. Sep 2008 A1
20080255642 Zarins et al. Oct 2008 A1
20080262491 Swoyer et al. Oct 2008 A1
20080269862 Elmouelhi et al. Oct 2008 A1
20080281315 Gines Nov 2008 A1
20080294158 Pappone et al. Nov 2008 A1
20080300588 Groth et al. Dec 2008 A1
20090012516 Curtis et al. Jan 2009 A1
20090048589 Takashino et al. Feb 2009 A1
20090076506 Baker Mar 2009 A1
20090076534 Shelton, IV et al. Mar 2009 A1
20090082766 Unger et al. Mar 2009 A1
20090099582 Isaacs et al. Apr 2009 A1
20090112229 Omori et al. Apr 2009 A1
20090125026 Rioux et al. May 2009 A1
20090125027 Fischer May 2009 A1
20090131929 Shimizu May 2009 A1
20090138003 Deville et al. May 2009 A1
20090138006 Bales et al. May 2009 A1
20090182322 D'Amelio et al. Jul 2009 A1
20090182331 D'Amelio et al. Jul 2009 A1
20090182332 Long et al. Jul 2009 A1
20090206140 Scheib et al. Aug 2009 A1
20090209979 Yates et al. Aug 2009 A1
20090248002 Takashino et al. Oct 2009 A1
20090248021 McKenna Oct 2009 A1
20090254080 Honda Oct 2009 A1
20090287205 Ingle Nov 2009 A1
20090320268 Cunningham et al. Dec 2009 A1
20090326530 Orban, III et al. Dec 2009 A1
20100032470 Hess et al. Feb 2010 A1
20100036370 Mirel et al. Feb 2010 A1
20100036380 Taylor et al. Feb 2010 A1
20100076433 Taylor et al. Mar 2010 A1
20100081863 Hess et al. Apr 2010 A1
20100081864 Hess et al. Apr 2010 A1
20100081880 Widenhouse et al. Apr 2010 A1
20100081881 Murray et al. Apr 2010 A1
20100081882 Hess et al. Apr 2010 A1
20100081883 Murray et al. Apr 2010 A1
20100081995 Widenhouse et al. Apr 2010 A1
20100094323 Isaacs et al. Apr 2010 A1
20100168620 Klimovitch et al. Jul 2010 A1
20100222752 Collins, Jr. et al. Sep 2010 A1
20100237132 Measamer et al. Sep 2010 A1
20100264194 Huang et al. Oct 2010 A1
20100274278 Fleenor et al. Oct 2010 A1
20110015627 Dinardo et al. Jan 2011 A1
20110082486 Messerly et al. Apr 2011 A1
20110087214 Giordano et al. Apr 2011 A1
20110087215 Aldridge et al. Apr 2011 A1
20110087216 Aldridge et al. Apr 2011 A1
20110087217 Yates et al. Apr 2011 A1
20110087220 Felder et al. Apr 2011 A1
20110118754 Dachs, II et al. May 2011 A1
20110155781 Swensgard et al. Jun 2011 A1
20110224668 Johnson et al. Sep 2011 A1
20110276049 Gerhardt Nov 2011 A1
20110276057 Conlon et al. Nov 2011 A1
20110278343 Knodel et al. Nov 2011 A1
20110284014 Cadeddu et al. Nov 2011 A1
20110290856 Shelton, IV et al. Dec 2011 A1
20110295269 Swensgard et al. Dec 2011 A1
20110295295 Shelton, IV et al. Dec 2011 A1
20110301605 Horner Dec 2011 A1
20110306967 Payne et al. Dec 2011 A1
20110313415 Fernandez et al. Dec 2011 A1
20120016413 Timm et al. Jan 2012 A1
20120022519 Huang et al. Jan 2012 A1
20120022526 Aldridge et al. Jan 2012 A1
20120078139 Aldridge et al. Mar 2012 A1
20120078243 Worrell et al. Mar 2012 A1
20120078244 Worrell et al. Mar 2012 A1
20120078247 Worrell et al. Mar 2012 A1
20120078248 Worrell et al. Mar 2012 A1
20120083783 Davison et al. Apr 2012 A1
20120109186 Parrott et al. May 2012 A1
20120116265 Houser et al. May 2012 A1
20120116379 Yates et al. May 2012 A1
20120116380 Madan et al. May 2012 A1
20120116391 Houser et al. May 2012 A1
20120130256 Buysse et al. May 2012 A1
20120136353 Romero May 2012 A1
20120138660 Shelton, IV Jun 2012 A1
20120150170 Buysse et al. Jun 2012 A1
20120150192 Dachs, II et al. Jun 2012 A1
20120172859 Condie et al. Jul 2012 A1
20120265196 Turner et al. Oct 2012 A1
20120265241 Hart et al. Oct 2012 A1
20120296371 Kappus et al. Nov 2012 A1
20120323238 Tyrrell et al. Dec 2012 A1
20130023925 Mueller Jan 2013 A1
20130030428 Worrell et al. Jan 2013 A1
20130030433 Heard Jan 2013 A1
20130035685 Fischer et al. Feb 2013 A1
20130079762 Twomey et al. Mar 2013 A1
20130085496 Unger et al. Apr 2013 A1
20130123776 Monson et al. May 2013 A1
20130158659 Bergs et al. Jun 2013 A1
20130158660 Bergs et al. Jun 2013 A1
20130253256 Griffith et al. Sep 2013 A1
20130253502 Aronow et al. Sep 2013 A1
20130296843 Boudreaux et al. Nov 2013 A1
20130338661 Behnke, II Dec 2013 A1
20140001231 Shelton, IV et al. Jan 2014 A1
20140001234 Shelton, IV et al. Jan 2014 A1
20140001235 Shelton, IV Jan 2014 A1
20140001236 Shelton, IV et al. Jan 2014 A1
20140005640 Shelton, IV et al. Jan 2014 A1
20140005653 Shelton, IV et al. Jan 2014 A1
20140005678 Shelton, IV et al. Jan 2014 A1
20140005680 Shelton, IV et al. Jan 2014 A1
20140005681 Gee et al. Jan 2014 A1
20140005693 Shelton, IV et al. Jan 2014 A1
20140005694 Shelton, IV et al. Jan 2014 A1
20140005695 Shelton, IV Jan 2014 A1
20140005701 Olson et al. Jan 2014 A1
20140005702 Timm et al. Jan 2014 A1
20140005703 Stulen et al. Jan 2014 A1
20140005705 Weir et al. Jan 2014 A1
20140005718 Shelton, IV et al. Jan 2014 A1
20140014544 Bugnard et al. Jan 2014 A1
20140094801 Boudreaux et al. Apr 2014 A1
20140180281 Rusin Jun 2014 A1
20140194874 Dietz et al. Jul 2014 A1
20140194875 Reschke et al. Jul 2014 A1
20140194915 Johnson et al. Jul 2014 A1
20140214019 Baxter, III et al. Jul 2014 A1
20140228844 Hörlle et al. Aug 2014 A1
20140257284 Artale Sep 2014 A1
20140303551 Germain et al. Oct 2014 A1
20140316408 Davison et al. Oct 2014 A1
20140330271 Dietz et al. Nov 2014 A1
20140343550 Faller et al. Nov 2014 A1
20150018826 Boudreaux Jan 2015 A1
20150080876 Worrell et al. Mar 2015 A1
20150080879 Trees et al. Mar 2015 A1
20150080891 Shelton, IV et al. Mar 2015 A1
20150133915 Strobl et al. May 2015 A1
20150133929 Evans et al. May 2015 A1
20150141981 Price et al. May 2015 A1
20150190189 Yates et al. Jul 2015 A1
20150196352 Beckman et al. Jul 2015 A1
20150230853 Johnson et al. Aug 2015 A1
20150230861 Woloszko et al. Aug 2015 A1
20150265347 Yates et al. Sep 2015 A1
20150272602 Boudreaux et al. Oct 2015 A1
20150272657 Yates et al. Oct 2015 A1
20150272659 Boudreaux et al. Oct 2015 A1
20150272660 Boudreaux et al. Oct 2015 A1
20150289925 Voegele et al. Oct 2015 A1
20150297286 Boudreaux et al. Oct 2015 A1
20160045248 Unger et al. Feb 2016 A1
20160051315 Boudreaux Feb 2016 A1
20160051316 Boudreaux Feb 2016 A1
20160051317 Boudreaux Feb 2016 A1
20160058492 Yates et al. Mar 2016 A1
20160074108 Woodruff et al. Mar 2016 A1
20160128762 Harris et al. May 2016 A1
20160135875 Strobl et al. May 2016 A1
20160157927 Corbett et al. Jun 2016 A1
20160175024 Yates et al. Jun 2016 A1
20160175028 Trees et al. Jun 2016 A1
20160175029 Witt et al. Jun 2016 A1
20160175030 Boudreaux Jun 2016 A1
20160175031 Boudreaux Jun 2016 A1
20160175032 Yang Jun 2016 A1
20160199123 Thomas et al. Jul 2016 A1
20160199125 Jones Jul 2016 A1
20160228171 Boudreaux Aug 2016 A1
20160270840 Yates et al. Sep 2016 A1
20160270841 Strobl et al. Sep 2016 A1
20160270842 Strobl et al. Sep 2016 A1
20160270843 Boudreaux et al. Sep 2016 A1
20160278848 Boudreaux et al. Sep 2016 A1
20160296268 Gee et al. Oct 2016 A1
20160296270 Strobl et al. Oct 2016 A1
20160296271 Danziger et al. Oct 2016 A1
20160302844 Strobl et al. Oct 2016 A1
20160317215 Worrell et al. Nov 2016 A1
Foreign Referenced Citations (108)
Number Date Country
2868227 Feb 2007 CN
102834069 Dec 2012 CN
4300307 Jul 1994 DE
19608716 Apr 1997 DE
29623113 Oct 1997 DE
20004812 Sep 2000 DE
10201569 Jul 2003 DE
0340803 Aug 1993 EP
0630612 Dec 1994 EP
0705571 Apr 1996 EP
0557806 May 1998 EP
0640317 Sep 1999 EP
0722696 Dec 2002 EP
1293172 Apr 2006 EP
0875209 May 2006 EP
1704824 Sep 2006 EP
1749479 Feb 2007 EP
1767157 Mar 2007 EP
1254637 Aug 2007 EP
1878399 Jan 2008 EP
1915953 Apr 2008 EP
1532933 May 2008 EP
1707143 Jun 2008 EP
1943957 Jul 2008 EP
1435852 Dec 2008 EP
1849424 Apr 2009 EP
2042117 Apr 2009 EP
2060238 May 2009 EP
1810625 Aug 2009 EP
2090238 Aug 2009 EP
2090256 Aug 2009 EP
2092905 Aug 2009 EP
2105104 Sep 2009 EP
1747761 Oct 2009 EP
1769766 Feb 2010 EP
2151204 Feb 2010 EP
2153791 Feb 2010 EP
2243439 Oct 2010 EP
1510178 Jun 2011 EP
1728475 Aug 2011 EP
2353518 Aug 2011 EP
2529681 Dec 2012 EP
1767164 Jan 2013 EP
2316359 Mar 2013 EP
2578172 Apr 2013 EP
2508143 Feb 2014 EP
2472216 Feb 2011 GB
H 08-229050 Sep 1996 JP
2008-018226 Jan 2008 JP
5714508 May 2015 JP
WO 8103272 Nov 1981 WO
WO 9307817 Apr 1993 WO
WO 9322973 Nov 1993 WO
WO 9510978 Apr 1995 WO
WO 9635382 Nov 1996 WO
WO 9710764 Mar 1997 WO
WO 9800069 Jan 1998 WO
WO 9840020 Sep 1998 WO
WO 9857588 Dec 1998 WO
WO 9923960 May 1999 WO
WO 9940857 Aug 1999 WO
WO 9940861 Aug 1999 WO
WO 0024330 May 2000 WO
WO 0024331 May 2000 WO
WO 0025691 May 2000 WO
WO 0128444 Apr 2001 WO
WO 02062241 Aug 2002 WO
WO 02080797 Oct 2002 WO
WO 03001986 Jan 2003 WO
WO 03013374 Feb 2003 WO
WO 03020339 Mar 2003 WO
WO 03028541 Apr 2003 WO
WO 03030708 Apr 2003 WO
WO 03068046 Aug 2003 WO
WO 2004011037 Feb 2004 WO
WO 2004032754 Apr 2004 WO
WO 2004032762 Apr 2004 WO
WO 2004032763 Apr 2004 WO
WO 2004078051 Sep 2004 WO
WO 2004112618 Dec 2004 WO
WO 2005052959 Jun 2005 WO
WO 2006021269 Mar 2006 WO
WO 2006036706 Apr 2006 WO
WO 2006055166 May 2006 WO
WO 2006119139 Nov 2006 WO
WO 2008020964 Feb 2008 WO
WO 2008045348 Apr 2008 WO
WO 2008099529 Aug 2008 WO
WO 2008101356 Aug 2008 WO
WO 2009022614 Feb 2009 WO
WO 2009036818 Mar 2009 WO
WO 2009039179 Mar 2009 WO
WO 2009059741 May 2009 WO
WO 2009082477 Jul 2009 WO
WO 2009149234 Dec 2009 WO
WO 2010017266 Feb 2010 WO
WO 2010104755 Sep 2010 WO
WO 2011008672 Jan 2011 WO
WO 2011084768 Jul 2011 WO
WO 2011089717 Jul 2011 WO
WO 2011144911 Nov 2011 WO
WO 2012044606 Apr 2012 WO
WO 2012166510 Dec 2012 WO
WO 2013034629 Mar 2013 WO
WO 2013062978 May 2013 WO
WO 2013102602 Jul 2013 WO
WO 2013154157 Oct 2013 WO
WO 2015197395 Dec 2015 WO
Non-Patent Literature Citations (42)
Entry
Weir, C.E., “Rate of shrinkage of tendon collagen—heat, entropy and free energy of activation of the shrinkage of untreated tendon. Effect of acid salt, pickle, and tannage on the activation of tendon collagen.” Journal of the American Leather Chemists Association, 44, pp. 108-140 (1949).
Hörmann et al., “Reversible and irreversible denaturation of collagen fibers.” Biochemistry, 10, pp. 932-937 (1971).
Henriques. F.C., “Studies in thermal injury V. The predictability and the significance of thermally induced rate processes leading to irreversible epidermal injury.” Archives of Pathology, 434, pp. 489-502 (1947).
Arnoczky et al., “Thermal Modification of Conective Tissues: Basic Science Considerations and Clinical Implications,” J. Am Acad Orthop Surg, vol. 8, No. 5, pp. 305-313 (Sep./Oct. 2000).
Chen et al., “Heat-induced changes in the mechanics of a collagenous tissue: pseudoelastic behavior at 37° C.,” Journal of Biomechanics, 31, pp. 211-216 (1998).
Chen et al., “Heat-Induced Changes in the Mechanics of a Collagenous Tissue: Isothermal Free Shrinkage,” Transactions of the ASME, vol. 119, pp. 372-378 (Nov. 1997).
Chen et al., “Heat-Induced Changes in the Mechanics of a Collagenous Tissue: Isothermal, Isotonic Shrinkage,” Transactions of the ASME, vol. 120, pp. 382-388 (Jun. 1998).
Chen et al., “Phenomenological Evolution Equations for Heat-Induced Shrinkage of a Collagenous Tissue,” IEEE Transactions on Biomedical Engineering, vol. 45, No. 10, pp. 1234-1240 (Oct. 1998).
Harris et al., “Kinetics of Thermal Damage to a Collagenous Membrane Under Biaxial Isotonic Loading,” IEEE Transactions on Biomedical Engineering, vol. 51, No. 2, pp. 371-379 (Feb. 2004).
Harris et al., “Altered Mechanical Behavior of Epicardium Due to Isothermal Heating Under Biaxial Isotonic Loads,” Journal of Biomechanical Engineering, vol. 125, pp. 381-388 (Jun. 2003).
Hayashi et al., “The Effect of Thermal Heating on the Length and Histologic Properties of the Glenohumeral Joint Capsule,” American Journal of Sports Medicine, vol. 25, Issue 1, 11 pages (Jan. 1997), URL: http://www.mdconsult.com/das/article/body/156183648-2/jorg=journal&source=MI&sp=1 . . . , accessed Aug. 25, 2009.
Lee et al., “A multi-sample denaturation temperature tester for collagenous biomaterials,” Med. Eng. Phy., vol. 17, No. 2, pp. 115-121 (Mar. 1995).
Moran et al., “Thermally Induced Shrinkage of Joint Capsule,” Clinical Orthopaedics and Related Research, No. 281, pp. 248-255 (Dec. 2000).
Wall et al., “Thermal modification of collagen,” J Shoulder Elbow Surg, No. 8, pp. 339-344 (Jul./Aug. 1999).
Wells et al., “Altered Mechanical Behavior of Epicardium Under Isothermal Biaxial Loading,” Transactions of the ASME, Journal of Biomedical Engineering, vol. 126, pp. 492-497 (Aug. 2004).
Gibson, “Magnetic Refrigerator Successfully Tested,” U.S. Department of Energy Research News, accessed online on Aug. 6, 2010 at http://www.eurekalert.org/features/doe/2001-11/d1-mrs062802.php (Nov. 1, 2001).
Humphrey, J.D., “Continuum Thermomechanics and the Clinical Treatment of Disease and Injury,” Appl. Mech. Rev., vol. 56, No. 2 pp. 231-260 (Mar. 2003).
Kurt Gieck & Reiner Gieck, Engineering Formulas § Z.7 (7th ed. 1997).
National Semiconductors Temperature Sensor Handbook—http://www.national.com/appinfo/tempsensors/files/temphb.pdf; accessed online: Apr. 1, 2011.
Glaser and Subak-Sharpe, Integrated Circuit Engineering, Addison-Wesley Publishing, Reading, MA (1979). (book—not attached).
Wright, et al., “Time-Temperature Equivalence of Heat-Induced Changes in Cells and Proteins,” Feb. 1998. ASME Journal of Biomechanical Engineering, vol. 120, pp. 22-26.
Covidien Brochure, [Value Analysis Brief], LigaSure Advance™ Pistol Grip, dated Rev. Apr. 2010 (7 pages).
Covidien Brochure, LigaSure Impact™ Instrument LF4318, dated Feb. 2013 (3 pages).
Covidien Brochure, LigaSure Atlas™ Hand Switching Instruments, dated Dec. 2008 (2 pages).
Covidien Brochure, The LigaSure™ 5 mm Blunt Tip Sealer/Divider Family, dated Apr. 2013 (2 pages).
Covidien Brochure, The LigaSure Precise™ Instrument, dated Mar. 2011 (2 pages).
Erbe Electrosurgery VIO® S, (2012), p. 7, 12 pages, accessed Mar. 31, 2014 at http://www.erbe-med.com/erbe/media/Marketingmaterialien/85140-170—ERBE—EN—VIO—200—S—D027541.
Jang, J. et al. “Neuro-fuzzy and Soft Computing.” Prentice Hall, 1997, p. 13-89, 199-293, 335-393,453-496, 535-549.
Douglas, S.C. “Introduction to Adaptive Filter”. Digital Signal Processing Handbook. Ed. Vijay K. Madisetti and Douglas B. Williams. Boca Raton: CRC Press LLC, 1999.
Sullivan, “Cost-Constrained Selection of Strand Diameter and Number in a Litz-Wire Transformer Winding,” IEEE Transactions on Power Electronics, vol. 16, No. 2, Mar. 2001, pp. 281-288.
Sullivan, “Optimal Choice for Number of Strands in a Litz-Wire Transformer Winding,” IEEE Transactions on Power Electronics, vol. 14, No. 2, Mar. 1999, pp. 283-291.
https://www.kjmagnetics.com/fieldcalculator.asp, retrieved Jul. 11, 2016, backdated to Nov. 11, 2011 via https://web.archive.org/web/20111116164447/http://www.kjmagnetics.com/fieldcalculator.asp.
Leonard I. Malis, M.D., “The Value of Irrigation During Bipolar Coagulation,” 1989.
International Search Report for PCT/US2011/031147, dated Nov. 9, 2011 (7 pages).
International Preliminary Report on Patentability for PCT/US2011/031147, dated Oct. 16, 2012 (10 pages).
Written Opinion for PCT/US2011/031147, dated Nov. 9, 2011 (10 pages).
U.S. Appl. No. 12/576,529, filed Oct. 9, 2009.
U.S. Appl. No. 15/265,293, filed Sep. 14, 2016.
U.S. Appl. No. 15/258,570, filed Sep. 7, 2016.
U.S. Appl. No. 15/258,578, filed Sep. 7, 2016.
U.S. Appl. No. 15/258,586, filed Sep. 7, 2016.
U.S. Appl. No. 15/258,598, filed Sep. 7, 2016.
Related Publications (1)
Number Date Country
20140343550 A1 Nov 2014 US
Continuations (1)
Number Date Country
Parent 12758253 Apr 2010 US
Child 14450922 US